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ABSTRACT
Physician Perceptions of the Utility of Clinical Guidelines in the Management of People with
Type 2 Diabetes in Saudi Arabia
by
Abdulaziz Eskandarani

Claremont Graduate University: 2022
Aim: The aim of this research was to assess physicians’ perception of the utility of clinical
guidelines in the management of people with Type 2 diabetes in Saudi Arabia and how their
perception is affected by different physicians’ characteristics and whether high perception would
result in adherence to guidelines.
Methods: This study employed a cross-sectional study design and used a self-administered online
survey through Qualtrics software. The survey was distributed through the Saudi Society for
Diabetes (SSD) whose membership includes more than five-thousand active physicians from all
regions of Saudi Arabia. There were 493 respondents to the survey.
Results: Around half of the study participants (52.5%) were female, (50.9%) were aged 45 years
and below, (55.8%) were non-Saudis, (52.1%) of study participants were board-certified, (30.5%)
had more than 15 years of experience after getting the medical degree, (45.9%) had more than 15
years of experience in their specialization, and (27.6%) were from the Northern region. The key
findings of this research are: 1) physicians’ perceptions about the utility of clinical guidelines
significantly differed based on years of experience after obtaining their degree, the region of
practice, utilization of clinical guidelines to manage their patients, and the types of clinical
guidelines used to manage Type 2 diabetes patients; 2) having five to ten years of experience in

practicing specialty negatively affect physicians’ perception towards the utility of clinical
guidelines; 3) physicians who are aged over 55 years and those who reported having years of
experience in specialty over 5 years were more likely to use clinical guidelines to manage Type 2
diabetes patients (p≤0.01); and 4) physicians’ perception showed a negative mediation effect for
the age group 36-45 years and those who reported duration of experience of 11-15 years after
obtaining their degree on their utilization of clinical guidelines to manage Type 2 diabetes patients.
At the same time, physicians’ perception showed a positive mediation effect for those who reported
a duration of experience in the specialty of 15 years and above.
Conclusion: In general, physicians' perception of the utility of diabetes guidelines is positive.
Nevertheless, other parts of the healthcare system should be investigated and improved to acquire
new changes required for achieving optimum care.
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Chapter 1: Introduction

1.1.

Background
Diabetes mellitus (DM) is a condition characterized by an elevated blood glucose

concentration, also known as hyperglycemia (Sone 2018; Mayo Clinic Staff, 2020; Sperling,
Wolfsdorf et al., 2021). Diabetes mellitus is defined as a disturbed energy metabolism syndrome,
which alters fat, protein, and carbohydrate levels resulting from disorders in insulin function and\or
insulin secretion (American Diabetes Association, 2014; Sperling, Wolfsdorf et al., 2021).
Deficiencies in insulin function and impairment of insulin secretion often cohabit in the same
patient, and it is sometimes difficult to distinguish the difference between insulin deficiency and
impairment of insulin secretion, thus it is generally unknown or undetectable to pinpoint the
primary reason for hyperglycemia (American Diabetes Association, 2014).
The signs and symptoms of DM vary depending on the degree of hyperglycemia (Mayo
Clinic Staff, 2020). The classical DM signs and symptoms involve unexplained weight loss,
polyuria, polyphagia, and polydipsia (American Diabetes Association, 2014; Mayo Clinic Staff,
2020). Diabetes mellitus signs and symptoms also include fatigue, slow-healing sores, irritability,
and blurred vision. In some cases, chronic hyperglycemia could also be associated with exposure
to certain infections (like skin, vaginal, or/and gum infections) and growth impairment (American
Diabetes Association, 2014; Mayo Clinic Staff, 2020). The most intense clinical manifestations
for DM are non-ketotic hyperosmolar syndrome or ketoacidosis, which are outcomes from
uncontrolled DM, which is an acute life-threatening health status that may cause dehydration,
coma, and mortality in the lack of efficient therapy (American Diabetes Association, 2014).
Long-term uncontrolled DM is linked with systemic complications including (a)
macroangiopathy or macrovascular complications (cardiovascular diseases (CVDs) [peripheral
1

artery disease (PAD), stroke, and coronary heart disease (CHD)]), and (b) microvascular
complications (neuropathy, nephropathy, and retinopathy) (Carver and Abrahamson, 2009;
Abutaleb, 2016; Sone, 2018). Those complications result in a reduction in both the quality and
longevity of life. Moreover, DM patients are at an increased risk of other comorbidities including
cataracts, abnormalities of lipoprotein metabolism, nonalcoholic fatty liver disease, obesity, heart
failure, erectile dysfunction, hypertension, and some infectious diseases such as tuberculosis
(World Health Organization, 2019).
This introduction focuses on the etiologic classification and diagnosis of DM, as well as
risk factors, epidemiology, and management of DM.

1.2.

Etiologic Classification of Diabetes Mellitus
The conditions that existed at the time of the individual's DM diagnosis are usually used to

define the kind of DM the individual has (American Diabetes Association, 2014). However,
numerous people with DM do not readily fit into one category. For instance, despite the fact that
thiazides rarely raise blood sugar, long-term use may develop into DM. also, for individuals who
have already been diagnosed with type 2 DM or who were not yet diagnosed, thiazides can worsen
their condition. Similarly, a person who takes large doses of exogenous steroids (glucocorticoids)
may develop DM because of them, but as soon as he/she stops taking glucocorticoids, blood sugar
returns to the normal level, later the same person may experience repeated attacks of pancreatitis
for many years, resulting in the development of DM. Another instance is that an individual
diagnosed with gestational diabetes mellitus (GDM) may have persistent high blood sugar after
birth and may be specified to have type 2 DM. Incidentally, for the patient and physician,
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understanding the reason for hyperglycemia and efficiently treating it is more crucial than
categorizing a specific type of DM (American Diabetes Association, 2014).
According to the American Diabetes Association (ADA), the etiological classifications of
DM are discussed in the next section (American Diabetes Association, 2014).

1.2.1. Type 1 Diabetes Mellitus
A. Immune-Mediated Type 1 Diabetes Mellitus
Immune-mediated type 1 DM, also known as juvenile-onset diabetes or insulin-dependent
diabetes, is defined as a chronic immune-mediated disorder distinguished by the deficiency of
insulin resulting from the destruction of the pancreatic islet β-cells with hyperglycemia (American
Diabetes Association, 2014; Abutaleb, 2016).
Immune-mediated type 1 DM accounts for only 5-10% of individuals with DM. It can be
diagnosed at any age but predominantly affects children and adolescents. The rate of β-cell
destruction completely varies with this type of DM: it can be slow among some patients (mostly
adults) and fast among others (specifically children and infants). For children under 18 years of
age, the most prevalent type of autoimmune DM is characterized by a strong genetic susceptibility.
Ketoacidosis may also develop as the initial indication of the disorder, particularly in adolescents
and children. Modest fasting hyperglycemia may develop among other DM patients, in the
presence of stress or infection and can quickly transition to ketoacidosis and/or severe
hyperglycemia (American Diabetes Association, 2014; Abutaleb, 2016). However, other patients
(especially adults) could maintain the adequate function of residual β-cells that block ketoacidosis
for many years. Those patients will become at risk for ketoacidosis and rely on insulin for survival
once these functioning β-cells stop working. Thus, there is no or little insulin secretion in this later
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phase of the disorder, as indicated by undetectable or low C-peptide levels in plasma (American
Diabetes Association, 2014).
Immune-mediated DM is typically considered to be hereditable, even though the bulk of
patients do not have a family history of immune-mediated DM. In addition, autoimmune
destruction of β-cells is associated with environmental characteristics that are yet not well
understood and is likewise to also have numerous genetic tendencies (American Diabetes
Association, 2014; Abutaleb, 2016).
Patients rarely suffer from obesity when having this type of DM, yet the existence of obese
patients do not interfere with the diagnosis of this disorder. Those DM patients are too prone to
additional autoimmune conditions like the following: pernicious anemia, vitiligo, Hashimoto's
thyroiditis, myasthenia gravis, celiac sprue, Addison's disease, autoimmune hepatitis, and Graves'
disease (American Diabetes Association, 2014).
B. Idiopathic Type 1 Diabetes Mellitus
In 1984, idiopathic type 1 DM was first recognized (Ahren and Corrigan, 1985). Then two
subcategories of type 1 DM: (a) idiopathic type 1 DM and (b) classical autoimmune type 1 DM,
were proposed by the ADA in 1997 (The Expert Committee on the Diagnosis Classification of
Diabetes Mellitus, 1997). Most patients who fall into this category of type 1 DM are of Asian and
African American descent. It has also been characterized in European Mediterranean, Hispanic
Americans, and Native-American people. However, just a small fraction of individuals with type
1 DM are classified as idiopathic type 1 (Piñero-Piloña, Litonjua et al., 2001; Aguilera,
Casamitjana et al., 2004; American Diabetes Association, 2014).
Idiopathic type 1 DM is distinguished by persistent insulinopenia and is strongly inherited,
not associated with human leukocyte antigen (HLA), and missing immunological evidence of β-
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cell autoimmunity (American Diabetes Association 2014; Herman, Petersen et al., 2017). Patients
with idiopathic type 1 DM experience ketoacidosis episodes. Among those with regular
ketoacidosis episodes, those patients also display various degrees of insulin insufficiency (Dcct
Research Group, 1987; American Diabetes Association, 2014; Vellanki and Umpierrez, 2017).
Some distinctions do exist between patients with idiopathic type 1 DM and classical
autoimmune type 1 DM, even though idiopathic type 1 DM patients typically have similar disease
onset as classical autoimmune type 1 DM patients. Idiopathic type 1 DM patients have a
distinguishing span of the disorder, with a principal need for insulin treatment, typically for 6 to
18 months, and following proper management of the metabolic condition with oral therapy
(Banerji, Chaiken et al., 1994; Banerji, Chaiken et al., 1996; McFarlane, Chaiken et al., 2001;
Piñero-Piloña, Litonjua et al., 2001).
1.2.2. Type 2 Diabetes Mellitus
The most common type of DM is Type 2 DM, which accounts for more than 90% of all
DM cases in the world (International Diabetes Federation, 2021). Type 2 DM, formerly referred
to as adult-onset diabetes, type II diabetes, or non-insulin-dependent diabetes, involve people with
insulin resistance and generally have relative insulin deficiency (instead of absolute insulin
deficiency) at least in the beginning of the disease (American Diabetes Association, 2014;
Abutaleb, 2016). Those patients frequently do not require insulin therapy throughout their lifespan.
However, to best avoid chronic complications and lower blood glucose, insulin therapy may
eventually be required (American Diabetes Association, 2014; World Health Organization, 2019;
International Diabetes Federation, 2021).
In Type 2 DM, hyperglycemia is the consequence, in the first instance of a situation known
as insulin resistance (when body cells do not respond sufficiently to insulin). Insulin production
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rises during a time when the effectiveness of the insulin hormone is diminished, accompanied by
the onset of insulin resistance. With time, the pancreatic β-cells fail to keep up with the insulin
demand resulting in insufficient insulin production (American Diabetes Association 2014;
International Diabetes Federation, 2021).
An increasing number of adolescents and children are affected by Type 2 DM, though it is
more prevalent among adults. Most Type 2 DM patients are obese or overweight, which aggravates
or leads to insulin resistance. Type 2 DM patients who are not obese according to BMI criteria
may instead have visceral obesity, which is a raised ratio of body fat allocation often in the
abdominal region (Bogardus, Lillioja et al., 1985; Mooy, Grootenhuis et al., 1995; Stumvoll,
Goldstein et al., 2005; American Diabetes Association, 2014; International Diabetes Federation,
2021).
1.2.3. Gestational Diabetes Mellitus
Gestational diabetes mellitus (GDM) is defined as any level of glucose intolerance that
leads to hyperglycemia of variable riskiness that starts or first appears during pregnancy (American
Diabetes Association, 2014; Kleinwechter, Schäfer-Graf et al., 2014; American Diabetes
Association Professional Practice Committee, 2021). The description applies despite whether the
insulin therapy is utilized or not, or the circumstances continue after gestation. It is not impossible
that glucose intolerance existed before pregnancy, but it wasn't determined beforehand (American
Diabetes Association, 2014).
Gestational diabetes mellitus prevalence could range from 1 to 14% of pregnancies
globally (Qiu, Yu et al., 2017; Siddiqui and George, 2017). GDM affects 135,000 women in the
United States each year, accounting for 4% of all pregnancies in the country (Terranova, 2007).
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Furthermore, GDM is responsible for nearly 90% of all DM-complicated pregnancies (Kartik K.
Venkatesh, 2021).
1.2.4. Other Specific Types of Diabetes Mellitus
According to the ADA, the etiological classification of other specific types of DM are as
follows (American Diabetes Association, 2014):
A. Other genetic syndromes sometimes associated with diabetes can include the following:
Laurence-Moon-Biedl

syndrome,

Prader-Willi

syndrome,

Wolfram's

syndrome,

Huntington's chorea, Turner's syndrome, Porphyria, Klinefelter's syndrome, Friedreich's
ataxia, Down's syndrome, Myotonic dystrophy, and others.
B. Drug- or chemical-induced DM, which includes the following: β-adrenergic agonists, αInterferon, thyroid hormone, pentamidine, diazoxide, glucocorticoids, vacor, thiazides,
nicotinic acid, Dilantin, and others.
C. Genetic defects of β-cell function, which include the following: chromosome 2, NeuroD1
(MODY6), chromosome 20, HNF-4α (MODY1), chromosome 7, glucokinase (MODY2),
chromosome 12, HNF-1α (MODY3), Mitochondrial DNA, chromosome 17, HNF-1β
(MODY5), chromosome 13, insulin promoter factor-1 (IPF-1; MODY4), and others.
D. Diseases of the exocrine pancreas, which include the following: aldosteronoma,
hemochromatosis, neoplasia, pancreatitis, fibrocalculous pancreatopathy, cystic fibrosis,
trauma/pancreatectomy, and others.
E. Uncommon forms of immune-mediated diabetes, which include the following: anti-insulin
receptor antibodies, stiff-man syndrome, and others.
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F. Endocrinopathies, which include the following: hyperthyroidism, aldosteronoma,
glucagonoma, acromegaly, somatostatinoma, pheochromocytoma, Cushing's syndrome,
and others.
G. Genetic defects in insulin action, which include the following: lipoatrophic diabetes,
leprechaunism, type A insulin resistance, Rabson-Mendenhall syndrome, and others.
H. Infections, which include the following: cytomegalovirus, congenital rubella, and others.
1.3.

Diagnosis of Diabetes Mellitus
According to the ADA, the patient is diagnosed with diabetes if one or more of the

following criteria are met (American Diabetes Association Professional Practice Committee,
2021):
•

In a patient who has a hyperglycemic crisis or classic symptoms of hyperglycemia, a
random plasma glucose level of 11.1 mmol/L (200 mg/dL) or higher.

•

Fasting plasma glucose (FPG) level of 7.0 mmol/L (126 mg/dL) or higher. Fasting is
defined as not eating or drinking for at least 8 hours.

•

Glycosylated hemoglobin (A1C) level of 48 mmol/mol (6.5%) or higher (The test should
be conducted in a laboratory using a process that is National Glycohemoglobin
Standardization Program (NGSP) standardized and certified to the Diabetes Control and
Complications Trial (DCCT) assay).

•

Two-hour plasma glucose (2-h PG) level of 11.1 mmol/L (200 mg/dL) or higher during
oral glucose tolerance test (OGTT) (The test should be conducted as described by the
World Health Organization (WHO); utilizing a glucose load containing the equal of 75 g
anhydrous glucose dissolved in water).
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Diagnosis demands two abnormal results from two separate samples or the same sample when
unequivocal hyperglycemia cannot be established.
According to the ADA, the patient is diagnosed with prediabetes (prediabetes described as
a condition that places people at increased risk of developing DM and DM-related complications)
if one or more of the following criteria are met (American Diabetes Association Professional
Practice Committee, 2021):
•

A1C level from 39 mmol/mol (5.7%) to 47 mmol/mol (6.4%).

•

2-h PG during 75-g OGTT level from 7.8 mmol/L (140 mg/dL) to 11.0 mmol/L (199
mg/dL) (Impaired Glucose Tolerance (IGT)).

•

FPG level from 5.6 mmol/L (100 mg/dL) to 6.9 mmol/L (125 mg/dL) (Impaired Fasting
Glucose (IFG)).
According to the ADA, a patient is diagnosed with GDM by a one-step strategy, or a two-

step strategy as follows:
•

One-step strategy: Between 24 and 28 weeks of pregnancy, women who have never been
diagnosed with diabetes have a 75-gram OGTT, with plasma glucose levels tested after the
patient has fasted for 1 to 2 hours. After overnight fasting for at least 8 hours, an OGTT is
conducted in the morning. The patient is diagnosed with GMD if one or more of the
following criteria are met (American Diabetes Association Professional Practice
Committee, 2021):
o 2 h: level of 8.5 mmol/L (153 mg/dL) or higher.
o 1 h: level of 10.0 mmol/L (180 mg/dL) or higher.
o Fasting: level of 5.1 mmol/L (92 mg/dL) or higher.
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•

Two-step strategy
Step One: For women who were not prior diagnosed with DM between 24 and 28 weeks
of gestation, a 50-g Glucose Load Test (GLT) (non-fasting) is performed, with plasma
glucose measured at 1 h. After one hour, if the load of the plasma glucose level measured
is equal to 7.2, 7.5, or 7.8 mmol/L (130, 135, or 140 mg/dL, respectively) or higher, move
to a 100-g OGTT (American Diabetes Association Professional Practice Committee,
2021).
Step Two: When the patient is fasting, the 100-g OGTT should be performed. The patient
is diagnosed with GMD if two or more of the following criteria are met (Carpenter and
Coustan 1982; American Diabetes Association Professional Practice Committee, 2021):
o 3 h: level of 7.8 mmol/L (140 mg/dL) or higher.
o 2 h: level of 8.6 mmol/L (155 mg/dL) or higher.
o 1 h: level of 10.0 mmol/L (180 mg/dL) or higher.
o Fasting: level of 5.3 mmol/L (95 mg/dL) or higher.

The American College of Obstetricians and Gynecologists remarks that one raised value can be
utilized for GMD diagnosis (Bulletins-Obstetrics, 2018).
1.4.

Diabetes Mellitus Risk Factors
The risk factors that increase the development of DM differ depending on the kind of DM

a patient has and will be discussed in the next few sections.
1.4.1. Risk Factors for Type 1 Diabetes Mellitus
Risk factors for Type 1 DM include the following: physical stress (like illness or surgery),
autoantibody presence (antibodies that erroneously attack patients’ body’s organs or tissues),
family history (having a sibling or parent with type 1 DM), exposure to viruses’ infections,
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pancreas injury (by accident infection, surgery, or tumor), and\or age (more potential to develop
at a child, teen, or young adult age) (Mayo Clinic Staff, 2020; Centers for Disease Control and
Prevention, 2021; Cleveland Clinic, 2021).
1.4.2. Risk Factors for Type 2 Diabetes Mellitus and Prediabetes
Risk factors for Type 2 DM and prediabetes include the following: race (Hispanic/Latino
American, Pacific Islander, Asian-American, or African-American), family history (having a
sibling or parent with type 2 DM, or prediabetes), high blood pressure, physically inactive,
overweight, low high-density lipoprotein (HDL) cholesterol, polycystic ovary syndrome, cigarette
smoking, age (45 or older), history of stroke or heart disease, high triglyceride level, and\or
gestational diabetes or delivering a baby who weighed more than nine pounds (Mayo Clinic Staff,
2020; Centers for Disease Control and Prevention, 2021; Cleveland Clinic, 2021).
1.4.3. Risk Factors for Gestational Diabetes Mellitus
Risk factors for gestational diabetes include the following: race (Pacific Islander, Alaska
Native, Hispanic/Latino American, African American, Native Hawaiian, or American Indian),
family history (having a sibling or parent with type 2 DM, or prediabetes), age (more than 25 years
old), overweight, and\or polycystic ovary syndrome (Mayo Clinic Staff, 2020; Centers for Disease
Control and Prevention, 2021; Cleveland Clinic, 2021).
1.5.

Epidemiology
Worldwide, the number of DM patients increased by 10.5% from 382 million in 2013 to

422 million in 2014 and increased by 2.91-fold between 1980 and 2014 (Shi and Hu, 2014;
Melmed, Polonsky et al., 2015; World Health Organization, 2018). Zhou, Lu et al., (2016)
explained the dramatic increase in the number of DM patients as 39.7% due to aging and
population growth, 28.5% because of increased prevalence, and 31.8% resulting from the
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interaction between these two factors. Globally, in 2021, it is estimated that 537 million individuals
have DM, which equals 10.5% of the worldwide adult population. By the years 2035, 2040, 2045,
it is expected that the number of individuals with DM will increase to 592 million, 642 million,
783 million, respectively (International Diabetes Federation, 2021).
Globally, from 1980 to 2014, the prevalence of DM has risen by 80.9% from 4.7% to 8.5%.
During the past three decades, the prevalence of DM has been steadily growing with low-and
middle-income countries growing faster than in high-income countries (World Health
Organization, 2018). A previous study found that the worldwide age-standardized DM prevalence
was estimated to have increased from 1980 to 2014 by 58.0% among women from 5.0% (95% CI
2.9–7.9) to 7.9% (95% CI 6.4–9.7), and by 109.3% among men from 4.3% (95% CI 2.4–7.0) to
9.0% (95% CI 7.2–11.1) (Zhou, Lu et al., 2016). Out of every ten people in the world, more than
one adult currently lives with DM. In addition, there is a rising list of countries in which out of
every five, one or more of the adult inhabitants has DM (International Diabetes Federation, 2021).
Additionally, a previous study that was conducted in the UK reported that there is a sharp increase
in the rate of hospital admission related to hyperglycemia in the past two decades (Naser, Wang et
al., 2018).
1.6.

Mortality
Diabetes mellitus ranks among the leading ten reasons for death worldwide (International

Diabetes Federation, 2021). Diabetes mellitus caused a death rate of 1.5 to 5.1 million individuals
annually between the global population in 2012 and 2013, becoming the top eighth reason for
mortality in the world (World Health Organization, 2018). Among diabetic patients, DM at least
doubles the risk of mortality. Diabetes mellitus patients are at risk of developing many lifethreatening and debilitating complications (Alwafi, Alsharif et al., 2020), thus, causing a reduced
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quality of life, premature death (i.e., before the age of 70), and a raised necessity for medical care
(International Diabetes Federation, 2021). The premature death rate from DM increased by 5%
between 2000 and 2016. Diabetes mellitus directly caused 1.5 million deaths in 2019, where deaths
before the age of 70 accounted for 48% of all deaths due to DM (World Health Organization,
2021). In 2021, among the ages of 20-79, it is estimated that about 6.7 million adults have died
from DM or its complications [except for the risks of deaths connected with the coronavirus
disease 2019 (COVID-19) pandemic]. Where deaths under the age of 60 accounted for 32.6% of
all deaths due to DM during 2021 (International Diabetes Federation, 2021).
According to the WHO, DM associated risk factors (like being obese or overweight) are
growing. Moreover, the WHO has found that DM is a substantial reason for lower limb amputation,
kidney failure, blindness, and further long-term complications that significantly influences the
quality of life. Hence, the rates of limb amputation are higher among DM individuals by 10 to 20
times (World Health Organization, 2018).
1.7.

Economic Burden
Over the past 15 years from (2006 to 2021), international health spending due to DM has

significantly increased by 3.2-fold from $232 billion to $966 billion for adult patients aged 20 to
79 years. Improving data quality could be the reason in part for this increase. The direct costs of
diabetes and its complications are expected to continue to grow (Naser, Alwafi et al., 2020;
International Diabetes Federation, 2021). Compared to 2021, the International Diabetes Federation
assumes that the entire DM-related health spending will rise by 66.4% by 2030 and 9.1% by 2045,
reaching $1.03 trillion and $1.05 trillion, respectively (International Diabetes Federation, 2021).
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1.8.
•

Management of Diabetes Mellitus
Treatment Goals: Treatment goal guidance from the American Association of Clinical
Endocrinologists and American College of Endocrinology (AACE/ACE) and ADA are alike.
For general individuals with DM, the ADA treatment goals involve the following criteria
(American Diabetes Association Professional Practice Committee, 2021):
o Peak postprandial glucose less than 10.0 mmol/L (180 mg/dL).
o A1C less than 8% for people with specific comorbidities or severe hypoglycemia,
less than 6.5% for select healthy people; equal or less than 7% for most.
o Blood pressure less than 130/80 for some healthy people; less than 140/90 mmHg
for most (American Diabetes Association Professional Practice Committee, 2021).
o Pre-prandial glucose level from 4.4 to 7.2 mmol/L (80–130 mg/dL).

Concerning glycemic goals among women who have DM before gestation, ADA
recommendations include the following (American Diabetes Association, 2014):
o A1C less than 6.0%.
o Peak postprandial glucose level from 5.4 to 7.1 mmol/L (100–129 mg/dL).
o Bedtime, premeal, and overnight glucose level from 3.3 to 5.4 mmol/L (60–99
mg/dL).
For pregnant DM patients, treatment goals are slightly different from the general DM patients.
According to the ADA, the glycemic goals for GDM patients include pre-prandial of less than 5.3
mmol/L (95 mg/dL) and either of the following (American Diabetes Association Professional
Practice Committee, 2021):
o 2-hour after meal less than 6.7 mmol/L (120 mg/dL).
o OR 1-hour after meal less than 7.8 mmol/L (140 mg/dL).

14

a. Pharmacological Management
Type 1 DM demands direct initiation of insulin treatment: insulin with meals or prandial
insulin, and basal insulin (rapid-acting insulin with a pump, or long-acting or intermediate by
injection). For sufficient glycemic control, several insulin injections throughout the day are
required (Handelsman, Bloomgarden et al., 2015; American Diabetes Association Professional
Practice Committee, 2021)
For Type 2 DM patients, metformin is recommended for management unless
contraindicated or not tolerated. When oral antidiabetic agents as monotherapy or combination
therapy (such as the following: glucagon-like peptide-1 (GLP-1) agonists, sulfonylureas, sodiumglucose cotransporter 2 inhibitors, alpha-glucosidase inhibitors, dipeptidyl peptidase 4 inhibitors,
and thiazolidinedione) is not efficacious among patients with Type 2 DM, usually insulin therapy
is demanded (Naser, Wong et al., 2018). If a patient with Type 2 DM has symptoms of
hyperglycemia (frequent urination, increased thirst) and has A1c greater than 9.0%, they may even
start with insulin therapy. To avoid hypoglycemia and achieve proper glycemic control with
prandial insulin, it is important to balance the intake of carbohydrates (Handelsman, Bloomgarden
et al., 2015; American Diabetes Association Professional Practice Committee, 2021).
Pharmacologic treatment of DM during gestation varies among individuals. The standard
therapy for DM during gestation is insulin. Some oral medications have been used during gestation
without adverse side effects among some patients, including metformin and glyburide
(Handelsman, Bloomgarden et al., 2015; American Diabetes Association Professional Practice
Committee, 2021; American Diabetes Association Professional Practice Committee, 2021).
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b. Non-Pharmacological Treatment
Along with reducing blood glucose and the levels of further known risk factors that impair
the blood vessels, treatment of DM involves physical activity and a healthy diet (World Health
Organization, 2021). Smoking cessation is even a more significant change to avoid DM
complications (World Health Organization, 2021).
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Chapter 2: Literature Review

2.1 Overview
An essential part of implementing and maintaining the use of guidelines is understanding
how physicians behave toward guidelines. Chapter 2 discusses what previous studies have found
on physicians’ behavior towards utilizing diabetes clinical guidelines while managing patients with
diabetes mellitus.
2.2 Literature Review
Published evidence suggested that properly utilizing clinical practice guidelines for Type
2 diabetes can improve glycemic control, lipid profiles, and patient satisfaction with their care
(Goldfracht & Porath, 2000; Kirkman et al., 2002; Gross et al., 2003). The utilization of
unnecessary medications and procedures that provide little or no benefit is reduced when medical
standards of care are followed. This practice enhances cost-effectiveness, which is a top priority
in developing countries with limited healthcare budgets and resources that are already under
financial strain. Policymakers and managers use standards of care to plan health services, resource
allocation, and organizational development (National Health and Medical Research Council
(Australia), 1999; Leach & Segal, 2010).
Even though Type 2 diabetes clinical guidelines are readily available, several studies have
found that healthcare practitioners follow them inconsistently. The proportion of people with Type
2 diabetes who met ADA-recommended levels of glycated haemoglobin, blood pressure, and LowDensity Lipoprotein (LDL) cholesterol was examined in a large cross-sectional study using data
from the National Health and Nutrition Examination Surveys (NHANES) in the United States
(Stark Casagrande, 2013). Only 18% of patients with Type 2 diabetes who completed self-
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administered surveys between 1988 and 2010 met the recommended treatment goals (Stark
Casagrande, 2013). The researchers concluded that following the guidelines had a substantial
impact on their findings.
In a retrospective cohort study that used electronic health record data of 4,994 adults (age>
18 years) with Type 2 diabetes who visited Patisserie Teaching Hospital in South Korea between
2004 and 2009, Se-Won Oh et al., (2011) found that the proportion receiving routine screening for
eye disease, lipid abnormalities, and renal dysfunction were 32.8%, 45.9%, and 33.5%,
respectively. The investigators concluded that physicians were not sufficiently following the
clinical guidelines.
Despite their positive attitude toward clinical guidelines, many physicians do not follow
them (Farquhar et al., 2002). In persons with Type 2 diabetes, non-adherence can lead to
suboptimal treatment and needless investigations. Examining physicians' knowledge and
perceptions of guideline utility was crucial to enhance their adherence to and understanding of the
most up-to-date practice recommendations (Storm‐Versloot et al., 2012). In previous studies
conducted in Saudi Arabia to assess physicians' perceptions toward diabetes clinical practice
guidelines, attitudes toward clinical guidelines were generally positive (Amer et al., 2019;Wahabi,
2011). A cross-sectional study of 260 physicians and nurses working in the pediatrics department
at King Khalid University Hospital investigated their perceptions and attitudes toward diabetic
ketoacidosis guidelines. Clinical guidelines were viewed as a 'useful tool' for practice by nearly all
(99%) respondents because they promoted uniformity and safety while lowering patient risks.
Furthermore, 98% of physicians reported that they have confidence in clinical guidelines. The
study concluded that positive perceptions and attitudes of evidence-based guidelines are crucial to
their implementation and sustaining a safe and high-quality healthcare environment (Amer et al.,
18

2019). Another study in Saudi Arabia by Wahabi et al.(2011) reported that physicians had a
positive attitude towards clinical practice guideline (CPG)s

with 90% believing that

CPGs integrate patient care and 96% agreeing that CPGs increase the quality of services provided
(Wahabi, Alzeidan et al., 2011). The respondents' experience with CPGs matched their attitudes
and opinions. CPGs have changed the way they manage their patients, according to 86.3% of
respondents, and 71.8% reported they have already employed CPGs in patient management.
Physicians were substantially less likely than nurses to utilize CPGs in practice (p≤0.05).
Additionally, the usage of guidelines varies greatly depending on years of experience, with 71% of
respondents with 15 years or more experience using CPGs in their patient treatment compared to
60% among respondents with fewer years of experience (p<0.05) (Wahabi, Alzeidan et al., 2011).
Each phase in the implementation of guidelines, according to Grol et al., (1992), may
contain barriers that need to be better understood iorder to develop solutions to overcome them.
Furthermore, Grol et al. suggested that these barriers could be due to both individual practitioner
characteristics (e.g., motivation, age and experience, attitude, learning style, willingness to change,
and self-confidence) and the context in which they practice (logistics and also structure, social,
and organizational factors) (Grol, 1992).
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Table 1: Literature Review Findings

Study
author
(year)

(Amer,
Nemri et al.
2019)

Country

Saudi
Arabia

Study
Design

Crosssectional
survey

Study Aim

To explore
perception,
attitude, and
satisfaction of
paediatric
clinicians,
trainees, and
nurses at King
Khalid
University
Hospital
towards
clinical
practice
guidelines
(CPGs)
including the
locally
adapted
diabetic
ketoacidosis
CPG (DKACPG).

Physicians Specialty /
Settings

Sample Size

Findings related to
physicians’
adherence/perception/
use of clinical
guidelines while
managing patients
with diabetes mellitus
type 2
The respondents had a
good attitude toward
general clinical practice
guidelines (CPGs) and
specifically the diabetic
ketoacidosis (DKA)
CPG; 98.7% believed
CPGs were effective
sources of information,
enhanced safety and
risk, and reduced
variation in practice.

260

Doctors and nurses
working in the paediatrics
department.
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A total of 99.2% of
respondents thought
CPGs were good
clinical tools, 98.3
percent were satisfied
with, had trust in, and
would promote CPGs
to their colleagues, and
94.6% agreed they
were cost effective.
Paper (46.6%) and
electronic were the
most popular formats
for CPGs (42.9%). The
DKACPG aided in

Findings related to
barriers and
interventions used to
improve physicians
adherence/perception
/use of clinical
guidelines while
managing patients
with diabetes mellitus
type 2
They identified a
number of factors that
may have contributed
to the positive
perceptions and
attitudes toward
CPGs. The context or
health care setting at
the institution, which is
a university teaching
medical complex
where evidence-based
medicine and CPGs are
part of the
undergraduate and
postgraduate medical
school curricula, was
one of these. In
addition, the
paediatrics department
has been engaged in
continual quality
improvement projects
and efforts as a result
of national and
international
accreditation activities.

patient management,
and all responders were
satisfied and confident
in it (100%).
Physicians reported a
more positive attitude
of CPGs in general
(P≤0.05) and the
DKACPG (P≤0.05)
than nurses.

(Wahabi,
Alzeidan et
al. 2011)

Saudi
Arabia

Crosssectional
survey

To explore
the opinion
and practice
of the health
care providers
in King
Khalid
University
Hospital
(KKUH)
towards
clinical
practice
guidelines
(CPGs).

Physicians had a
positive attitude
towards CPGs with
90% believing that
clinical practice
guideline (CPG)s
integrate patient care
and 96% agreeing that
CPGs increase the
quality of services
provided

2225

Health care professionals
in King Khalid University
Hospital

The respondents'
experience with CPGs
matched their attitudes
and opinions. CPGs
have changed the way
they manage their
patients, according to
86.3% of respondents,
and 71.8% reported
they have already
employed CPGs in
patient management.
Physicians were
substantially less likely
than nurses to utilize
CPGs in practice
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They reported that
certain circumstances
improve health care
providers' use and
adherence to CPGs,
such as when the
guideline's source is a
credible and respected
body or organization,
when there is
consensus about the
benefit to patients, and
when supplies for
implementation, such
as medicine and
equipment, are
available.

(p≤0.05); also, the
usage of guidelines
varies greatly
depending on years of
experience, with 71%
of respondents with 15
years or more
experience using CPGs
in their patient
treatment compared to
60% among
respondents with less
years of experience
(p<0.05)

Rätsep,
Kalda et al.
(2006)

Gannon,
Qaseem et
al. (2010)

Estonia

Pennsylvani
a, USA

Crosssectional
survey

Longitudin
al study
(pre-post
intervention
design)

To compare
family
physicians'
information
and selfreported care
of patients
who have
type 2
diabetes with
the
recommended
criteria of the
clinical
practice
guidelines
(CPGs).
The main
research
objective of
this study was
to investigate
the effect of
an
educational

76% of the responding
family physicians had a
copy of the guideline.

163

Family doctors

79% of responding
family physicians
reported utilizing it in
daily practice.

Not applicable.

83% of the responding
family physicians
considered guideline
viable.

112
physicians
1172 patients
with type 2
diabetes

Health Organization in
Pennsylvania
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Not mentioned.

The Web-based
educational module
consists of 13 chapters
on diabetes education,
screening for
microalbumin,
diagnosis, blood
pressure, glycemic

intervention
on clinical
consequences
in type 2
diabetes
patients.

control, exercise
programs, weight loss,
lipids, vaccinations,
dilated eye
examination, foot
examination, and
smoking cessation.
Each chapter contains
information and a
review test. In
addition, selfassessment and
practice tools (patient
education and enabling
tools) are incorporated
in this module. There
is an exhaustive selfassessment part with
case studies at the end
of the module. When
new evidence becomes
available, the module
is updated online.
This study showed the
efficacy of utilizing
Web-based mediums to
modify physician
behaviour and
reinforce the utilization
of clinical guidelines.
Research outcomes
indicated persistent
improvements in most
clinical consequences.

Khan,
Lateef et al.
(2011)

Saudi
Arabia

Crosssectional
survey

To evaluate
the
Knowledge
Attitude and

99

General practitioners
(GPs)
Urban, and rural area.
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41% GPs had a copy of
CPGs.

This study advised the
necessity for
understanding and
educational program to

Overall KAP score of
GPs who did not have a
copy of CPGs in n their
clinic was (65.10
±7.01, P=.005), which
was lower than the
KAP score of GPs who
had a copy of CPGs
(70.90 ±10.94).

Practice
(KAP) of the
ministry of
health (MOH)
primary
health care
(PHC) medic
in the
managing of
type 2
diabetes.

Beaser,
Okeke et al.
(2011)

United
States

Crosssectional
survey

To identify
the
behavioral,
competence,
and
knowledge
issues among
diabetes
specialists
and primary
care providers
(PCPs)
concerning
the
application
and use of
evidencebased clinical
guidelines
and to
conform care
between

Practice score of GPs
who did not have CPG
in their clinic scored
remarkably lower than
GPs who had CPG in
their clinic (16.55 ±
7.34, vs 20.57 ± 7.54,
P< 0.003)

249 diabetes
specialists and
491 PCPs.

Internal medicine, family
medicine, nonendocrine
specialist primary care
provider, diabetologist,
endocrinologist,
obstetrician/gynecologist,
and others.
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18% of specialists and
36% of PCPs
continually utilized
treatment algorithms
and clinical guidelines
for managing
judgments concerning
their type 2 diabetes
patients.

update GPs
(particularly female,
Saudi doctors, and
those practicing in
urban places) on the
diagnostic criteria and
epidemiology for Type
2 diabetes and Diabetic
Self-Management
Education (DSME),
prevention of diabetes
complications of Type
2, adherence to CPG,
insulin injection
practice, and effective
diabetes treatment.

This study
recommended that
performance-based
educational
interventions and
quality-based
educational
interventions are
needed.

diabetes
specialists
and PCPs
especially
connected to
referral
practices for
Type 2
diabetes
patients.

Satman,
Imamoglu
et al. (2012)

Muzaffar,
Fatima et
al. (2013)

Turkey

Karachi,
Pakistan

National,
multiCentre
retrospectiv
e study

To assess
doctors’
compliance to
guidelines by
Diabetes
Study Group
of The
Society of
Endocrinolog
y and
Metabolism
of Turkey
(SEMT).

Retrospecti
ve study

To monitor
healthcare
professionals’
compliance to
the 2004
ADA
guidelines for
the care of
type 2
diabetes
patients in
Karachi in

180
physicians

Endocrinologist, internist,
and family practitioner.

1790 patients
with type 2
diabetes

Various types of hospitals
in all Turkey
geographical areas.

691 patients
with type 2
diabetes

Healthcare professionals
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Overall physicians’
adherence to guidelines
was suboptimal.
Approximately 50% of
patients obtained a high
level of care congruent
with SEMT guidelines
(>75% guidelines
adherents).
Guidelines adherence
among physicians and
specialists practicing in
university settings was
higher than those
practicing in other
settings.
Healthcare
professional’s
adherence to guidelines
was suboptimal. The
recommended ADA
goals were achieved as
follows: HDL in 4.9%
of patients, LDL in
12.2% of patients,
blood pressure in
13.0% of patients,
triglyceride in 13.3%

The study inferred
adherence to guidelines
can improve by
educational programs
that focus on the
preventative part of
managing diabetes.
which ultimately
improve patient
outcomes.

Not applicable.

peripheral
diabetes
clinics
(PDCs).

Widyahenin
g, Van Der
Graaf et al.
(2014)

Thepwongs
a, Kirby et
al. (2014)

Indonesia

Australia

Crosssectional
survey

Crosssectional
survey

To evaluate
the degree of
physicians'
adherence,
awareness,
adoption, and
agreement to
guidelines for
type 2
diabetes in
Indonesia and
their
connection
with
respondent
characteristics
.

To evaluate
existing KAP
in managing
type 2
diabetes for
GPs in the

of patients,
postprandial plasma
glucose in 17.7% of
patients, cholesterol in
27.5% of patients, preprandial plasma
glucose in 47.8% of
patients, and HbA1c in
59.0% of patients.
89% of GPs were
aware of the presence
of Indonesian
guidelines for type 2
diabetes.

GPs

399

Academic hospital, solo
practice, public health
centre, private clinic,
public hospital (nonacademic), and private
hospital.

66% to 91% of GPs
were aware of each
recommendation of
Indonesian guidelines
for type 2 diabetes.
A high understanding
of the guideline does
not always result in
adherence to guideline
recommendations or
adoption guidelines.

The study inferred that
improving clinicians’
agreement with,
adoption of, and
understanding of
guidelines necessitate
integrating into
programs to enhance
adherence to the
guideline.

The publication and
production of
guidelines alone are not
adequate to guarantee
the implementation of
the research evidence.

209

GPs
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66.7% of GPs had
utilized guidelines "the
Diabetes management
in general practice:
Guideline for type 2

Only 1.5% of GPs
were presently
registered in education
or further specialized
training for the

remote and
rural
Australian
areas to
deliver
attentive
education
initiatives.

diabetes 2011/12" in
their daily practices.

management of
diabetes.

28.9% of GPs had not
utilized the guidelines.

67.0% of GPs declared
on their learning
necessities.

4.4% of GPs had not
heard of these
guidelines.

The study indicated
that the preferences of
GPs in persisting
medical information
and education may
enable forthcoming
activities to meet the
necessities of GPs,
particularly in remote
and rural areas.

53% of physicians
routinely use diabetes
guidelines.

Corriere,
Minang et
al. (2014)

United
States

Online
questionnai
re

To define
how often
guidelines are
utilized and
the
association to
physicians’
diabetesrelated
decision
making and
knowledge.

383

Primary care,
endocrinologist, and
other.
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This study found
considerable gaps in
understanding diabetes
treatments and
diabetes-linked
knowledge in
practicing physicians.
However, the diabetes
knowledge score for
physicians who don't
use guidelines was
significantly lower than
physicians who use
guidelines (2.76 ±
0.084 vs 3.37 ± 0.072;
p< 0.001). Moreover,
physicians who use
guidelines were
extremely more likely

The study points to the
necessity for enhancing
continuous medical
education among
medical practitioners
and potential training
in the treatment and
management of
diabetes.

to report a proper
understanding of Type
2 diabetes medicines
(OR = 2.99, 95% CI
1.95-4.61; p < 0.001).

Oude
Wesselink,
Lingsma et
al. (2015)

Alkhiari,
Alzayer et
al. (2018)

Netherlands

Hamilton,
Ontario,
(Canada)

Crosssectional
study

To investigate
the
connection
between
adherence to
guidelines
and patients'
health
consequences
also to
determine
adherence to
guidelines
among GPs
who provide
care for Type
2 diabetes
patients in
Dutch.

Retrospecti
ve
longitudinal
study

To evaluate
the present
Canadian
practice
guidelines
compliance
level for the
pharmacologi
cal managing
of inpatients
with Type 2
diabetes, and
whether it
impacts the
recurrence of

32 GPs
363 patients
with Type 2
diabetes

GPs

In Dutch, the
adherence to guidelines
among GPs who
provide care for Type 2
diabetes patients was
not optimal.

Not applicable.

This study did not find
a clear association
between adherence to
the guidelines and
health consequences.

82% of patients
received care based on
guidelines.

108 patients
with type 2
diabetes

Medical student/junior
resident, senior resident,
and attending physician.
Two academic teaching
hospitals in Hamilton,
Ontario.

Adherence level to the
current Canadian
guidelines for
managing Type 2
diabetes inpatient is
good.
Around one-third of
junior residents did not
follow the guidelines.
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The study inferred that
the compliance level is
better with more
clinical seniority and
training.

hypoglycemia
or
hyperglycemi
a.

Bili and
Zha (2018)

FranchNadal,
GarcíaGollarte et
al. (2019)

Juba, South
Sudan

Spain

Descriptive
crosssectional
study

Crosssectional
study.

To evaluate
the level of
compliance
and
knowledge to
guidelines for
managing
Type 2
diabetes and
determine
connections
between
HbA1C levels
and scores of
knowledges.

To clarify
routine
clinical
practice and
perceptions of
community
pharmacists
and
physicians in
the
management
of elderly
patients with
Type 2
diabetes.

Adherence to
guidelines was low.

176 adult’s
patients with
Type 2
diabetes

The Malakia Diabetic
Control Centre of Juba.

In the past year, only
10.2% of patients had
kidney function
reviews, 20.5% had
dental examinations,
37.5% had lipid
measurements, 44.3%
had HbA1c tests, and
46.6% had retinal
examinations.

The study inferred that
in South Sudan, the
educational
intervention and
execution of guidelines
for diabetes
management are
consequential.

Knowledge about
guidelines was poor.

999
community
pharmacists
and 993
physicians.

Community pharmacists
(with at least two years’
experience in Spain; in
the community pharmacy
domain).
Public health sector
physicians in Spain (with
a minimum of two years’
experience in their
specialty).
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Adherence to guideline
recommendations was
low. A total of 62.8%
of physicians reported
that they follow the
clinical guidelines
recommendations.
Contingent on
physicians' prescribing
decisions for
hypothetical patients,
less than 50% of
physicians were
consistent with the
guideline
recommendations.
HbA1c targets
(according to the
clinical guidelines)

Not applicable.

were defined by only
28.7% and 38.9% of
clinicians for frail
patients and elderly
patients, respectively.

SavonaVentura
and
Vassallo
(2019)

Gediminas,
Ida et al.
(2019)

Mediterrane
an region
countries

Lithuania

Crosssectional
survey

Retrospecti
ve study

To evaluate
compliance of
practitioners
working in
the
Mediterranea
n region to
the guidelines
and determine
causes for
nonadherence.
To examine
the adherence
of the
Lithuanian
family
physician
with the
national type
2 diabetes
guidelines
and to
evaluate the
associations
between
guidelines
adherence and
health care
practice
features and
patients.

2841

Diabetologist/endocrinolo
gist, primary health
physician,
cardiologist/internist, and
others.

79.2% of physicians
were aware of local
guidelines.

Not applicable.

Primary health, university
hospital, general hospital,
and others.

Adherence to type 2
diabetes guidelines in
Lithuanian PHC is not
optimal.

382 patients
with type 2
diabetes
6 private and
4 public PHC
medical
records

Family physician
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Annual BMI and LDL
checks were performed
only among 19.4% and
23.8% of patients,
respectively.
Endocrinologist
consultation was
provided only to 49.5%
of patients.

Not applicable.

Daud,
Ramli et al.
(2020)

Brenner,
Oberaigner
et al. (2020)

Malaysia

Germany

Pragmatic
Cluster
Randomize
d
Controlled
Trial

Crosssectional
survey

To assess the
efficacy of the
EMPOWERparticipatory
action
research
(PAR)
intervention, a
multifaceted
approach
contingent on
the chronic
care model
(CCM) on
PCP
compliance to
CPG of Type
2 diabetes in
the Malaysian
general
primary care
setting.

To catch the
physician
viewpoint on
compliance to
Type 2
diabetes
guidelines
and determine
factors for
raising
compliance.

20 clinics.
888 patients
with Type 2
diabetes.

Family Medicine
Specialists (FMS)

Not mentioned.

EMPOWER-PAR
consists of support,
CDM workshops, selfmanagement support
tool, type 2 DM CPG,
and facilitation.
EMPOWER-PAR
intervention has
effectively improved
the adherence of PCPs
to CPG of type 2
diabetes in numerous
indicators of care.
Conclusions from this
study delivered factual
evidence of the
efficacy of a
multifaceted
intervention contingent
on the CCM in the
general primary care
setting in Malaysia.

46

Specialist (inpatient, and
outpatient), and GP.

31

93% of participants
have very good or good
knowledge about
national treatment
guidelines.

Doctors have rated
several potential
barriers for adherence
to the guidelines,
including the
following: 41%
physician disapproval
of guideline, 35%
medical reasons, 41%
due to missing clinical
information, 50% due
to deficient physician
training, 54% nonalignment of guideline
and reimbursement,
and 63% deficient

cross-sectoral
coordination.
In this study, clinicians
valued adherence
enablers contingent on
digital solutions to
decrease the intricacy
of treatment
determinations and aid
the care approach.

Papanas,
Elisaf et al.
(2020)

Greece

Nationwide
, multiCentre,
crosssectional
study

To estimate
adherence of
doctor to the
patient
follow-up
protocol
(PFP) of the
2017 Hellenic
Diabetes
Association
(HDA)
guidelines,
and even
evaluated
control
achievement
rates for lipid,
blood
pressure, and
glycated
hemoglobin
(HbA1c) in
the routine
care
environment
in Greece.

4 GPs with an
express
interest in
diabetes, 14
endocrinologis
ts, 35
internists, and
610 patients
with Type 2
diabetes.

Endocrinologists, GPs,
and internists.
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Physicians followed
the: American
Association of Clinical
Endocrinologists/Amer
ican College of
Endocrinology
(AACE/ACE)
guidelines for
managing 8.8% of
patients, American
Diabetes
Association/European
Association for the
Study of Diabetes
(ADA/EASD)
guidelines for
managing 43.4% of
patients, and HDA
therapeutic guidelines
for managing 77.2% of
patients.

Not applicable.

Bimpas,
Auyeung et
al. (2021)

Gimeno,
Cánovas et
al. (2021)

Greece

Spain

Questionnai
re

Crosssectional
multicenter
study

To assess the
level of
adherence and
adoption of
Greek
physicians to
the HDA
guidelines for
the
management
of Type 2
diabetic
people.

To evaluate
factors
correlated
with
adherence to
Type 2
diabetes
clinical
practice
guidelines
(CPGs).

226

98

GPs, internists,
endocrinologists, and
others.

92.2% of participants
adopt/ follow HDA
guidelines.

Public hospital, private
setting, and both public
hospital and private
setting.

26.1% of participants
adherence to both
treatment and general
guidelines.

Endocrinologists

All of the participants
were knowledgeable
and utilized CPGs in
day-to-day practice as
follows: 8.2% use "the
CPG for the Prevention
and Management of
Diabetes in, Canada,
Professional Section of
Diabetes Canada",
10.2% use the National
Institute for Health and
Care Excellence
(NICE) for
management adults
with Type 2 diabetes,
34.7% use the Spanish
Society of Diabetes
(SED)
recommendations for
treatment of
hyperglycemia in type
2 diabetes
(pharmacological
treatment), 38.8% use
the AACE/ACE
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Adherence to treatment
guidelines is positively
affected by the rate of
attendance to diabetes
seminars.
Adherence to treatment
guidelines is negatively
affected by long
professional practice.

Not applicable.

"comprehensive type 2
diabetes management
algorithm", 79.6% use
the Spanish Society of
Endocrinology and
Nutrition (SEEN) in
the care of Type 2
diabetes patients, and
99% use the
ADA/EASD in the care
of Type 2 diabetes
patients.
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Much of the research mentioned above found varying results in terms of physicians' and
general practitioners' adherence to Type 2 diabetes guidelines in various countries. Some studies
reported that clinical guidelines adherence was good (Rätsep, Kalda et al., 2006; Thepwongsa,
Kirby et al., 2014; Alkhiari, Alzayer et al., 2018; Papanas, Elisaf et al., 2020; Gimeno, Cánovas et
al., 2021), while others reported that clinical guidelines adherence was low or suboptimal (Beaser,
Okeke et al., 2011; Satman, Imamoglu et al., 2012; Muzaffar, Fatima et al., 2013; Oude Wesselink,
Lingsma et al., 2015; Bili and Zha 2018; Franch-Nadal, García-Gollarte et al., 2019; Gediminas,
Ida et al., 2019). In addition, several studies have noted a high awareness of the guidelines for
Type 2 diabetes. According to several studies, a thorough knowledge of the principles does not
always imply adherence or adoption (Widyahening, Van Der Graaf et al., 2014; Franch-Nadal,
García-Gollarte et al., 2019; Bimpas, Auyeung et al., 2021).
Bimpas, Auyeung et al., (2021) concluded that adherence to treatment guidelines was
negatively affected by long professional practice, while Alkhiari, Alzayer et al., (2018) found that
it was positively affected by more clinical seniority. Additionally, Gannon, Qaseem et al., (2010)
have found a relationship between adherence to guidelines and health outcomes. On the other hand,
Oude Wesselink, Lingsma et al., (2015) have not found a clear connection between guidelines
adherence and health consequences. Patient non-adherence, individual patient characteristics, a
lack of knowledge, time constraints, flaws in the health-care system, insufficient human resources,
referral system difficulties, and a refusal to change practice are some of the reasons or barriers that
led to non-adherence to clinical guidelines (James, Cowan et al., 1997; Larme and Pugh 1998;
Chan, Ghazali et al., 2005; Gimeno, Cánovas et al., 2021).
Several interventions have been recommended and used to improve adherence of clinical
guidelines during the management of Type 2 diabetes patients and have had a positive effect. For
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instance, a previous study found a significant increase in physician adherence to clinical guidelines
for Type 2 diabetes after educating physicians about the Society of Endocrinology and Metabolism
of Turkey (SEMT) guidelines, which resulted in more rational treatment preferences, fewer
unnecessary treatments, and better glycemic control (Satman, Imamoglu et al., 2012). Moreover,
web-based medium and the EMPOWER-PAR intervention utilization enhanced physician’s
adherence to Type 2 diabetes guidelines and improved clinical outcomes for patients in Malaysia
and the Pennsylvania, USA (Gannon, Qaseem et al., 2010; Daud, Ramli et al., 2020). Also,
diabetes seminars attendance positively affected adherence to treatment guidelines among
physicians in Greece. Compared with participants who attended fewer than 2 diabetes
conferences/seminars

annually,

participants

who

attended

from

2

to

5

diabetes

conferences/seminars annually exhibited better adherence to treatment guidelines (p = 0.031)
(Bimpas, Auyeung et al., 2021).
Several previous studies have demonstrated that specialists adhere to clinical guidelines at
a higher rate than general practitioners (Pathman, Konrad et al., 1996; Brown, Harris et al., 2002;
Kahan, Friedman et al., 2005; Grossman, Silverman et al., 2013). Another research in the United
States found that while primary care physicians had similar number of guideline users and nonguideline users, endocrinologists had a higher proportion of guideline users than non-guideline
users (p = 0.01), and physicians from other subspecialties had a higher proportion of non-guideline
users (p = 0.003) (Corriere, Minang et al., 2014). Moreover, a previous study in Turkey found that
doctors and specialists working in university settings adhered to the guidelines better than doctors
and family practitioners working in state organizations (Satman, Imamoglu et al., 2012, Satman,
Imamoglu et al., 2012).
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Chapter 3: Methodology
3.1 Hypothesis
We hypothesized that physicians’ perception of T2D clinical practice guideline’s utility
impacts their use and adherence to clinical guidelines. Physician characteristics of age, gender,
practice region, training level, and board certification are associated with “following guidelines”
based on physician perception of guidelines utility (see Figure 1 structural causal model below).

Independent
variables

Board
Certification

Mediator

Dependent
variable

Perception
of
guidelines
utility

Years of
Experience
Following
Clinical
Guidelines
Age

Region of
practice

Gender

Figure 1: Study structural causal model
* The blue colored arrows highlighting the hypothesized direct association between the independent variables and the dependent
variable, and the black colored arrows highlight the indirect association between the independent variables and the dependent
variable mediated by the perception of guidelines utility.
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3.2 Study Design
This study employed a cross-sectional study design and used a self-administered online
survey through Qualtrics software.
3.3 The Survey
The survey (attached in the appendix) consisted of 14 questions divided into four parts.
The first part asked about demographics that included gender, age, nationality, board certification,
specialty, years of experience, and the region of practice. These questions helped in comparing the
perceptions of guidelines utility of different groups of physicians according to these demographics.
The second part asked the participants whether they use guidelines to manage their patients who
have diabetes mellitus “yes/no format question” (our dependent variable) and required participants
to choose which diabetes guidelines they refer to in their practice and have reliable access to. The
third part consisted of five questions that utilized a 5-point Likert scale and asked participants
about their perception towards the utility of guidelines (strongly agree “given a score of 5”, agree,
neither agree nor disagree, disagree, and strongly disagree “given a score of 1”). The maximum
obtainable total perception score is 25, the higher the score the more positive the perception of the
participants about the utility of diabetes clinical guidelines.
The five-point Likert scale covered different aspects of the utility (delivering evidencebased care, patients’ satisfaction, decreasing diabetes complications, and efficiency in time and
resources in care delivery). The fourth part consisted of one question that asked physicians to
choose the available services required for diabetes care in their clinics. This part helped in
understanding the availability of services and physicians’ adherence to recommended services.
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3.4 Sampling
Primary data was collected from healthcare providers in the Saudi Society for Diabetes
(SSD) database through a self-administered online survey using Qualtrics software. The survey
was distributed through the Saudi Society for Diabetes (SSD), whose membership includes more
than five-thousand active physicians from all regions of Saudi Arabia. The SSD forwarded the
survey to members and requested them to participate. The survey included a cover letter that
described the study and its purpose.
3.5 Data Analysis
The data from this study was analyzed using IBM SPSS version 27 (IBM Corp., Armonk,
N.Y., USA). Descriptive statistics were used to describe the characteristics of the study variables
as frequency and percentages for the categorical and nominal variables. At the same time, the mean
and standard deviation was used to present continuous variables. A Domain was used as the study
mediating variable, and it was compared to all indicators. This domain was called “Diabetes
Guidelines’ Perception Score.” The score was calculated by recoding the responses to the
following questions:
Following are a couple of statements about the usefulness of the diabetes guidelines.
•

Deliver evidence-based care.

•

Save time in patient care.

•

Contribute to efficient use of resources.

•

Increase my patients' satisfaction with care.

•

Decrease the risk of diabetes complications.
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Answers were recoded as follow:
•

Strongly agree = 5

•

Agree = 4

•

Neither agree nor disagree =3

•

Disagree = 2

•

Strongly disagree = 1
A Reliability Analysis was used with an Alpha (Cronbach) model to study the properties

of measurement scales and the items that compose the scales and the average inter-item correlation.
An independent t-test and One-way ANOVA, with Least Significant Difference (LSD) as a post
hoc test, respectively, were used to explore the difference in the mean perception score between
different demographic groups. These tests were done with the assumption of normal distribution.
Also, General Linear Model (GLM) Univariate Analysis was used to identify significant predictors
using the Main Effect model. Lastly, a conventional p-value p<0.05 was the criteria to reject the
null hypothesis. Additionally, we conducted a mediation analysis to explore whether participants’
perception about guidelines utility is influencing the relationship between independent variables
(demographic and practice characteristics) and our dependent variable (using clinical guideline to
manage diabetic patients). Binary logistic regression was used to identify predictors that affect the
use of clinical guidelines to manage diabetic patients.
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Chapter 4: Results
4.1 Participants Demographics
Out of 5000 questionnaires sent to practicing physicians, 501 were returned at least
partially completed. Three were excluded from the analysis because they came from pharmacists.
Another five were excluded because not all questions were answered. The final sample subjected
to analysis was 493 (response rate 9.9%).
Around half of the study participants (52.5%) were female. Similar percentage of the study
participants (50.9%) were aged 45 years and below. More than half of the study participants
(55.8%) were non-Saudis, including physicians from Egypt, India, Pakistan, Sudan, Jordan, and
Syria. A total of 52.1% of study participants were board-certified. The variations in the number of
years of experience of physicians after their degree were relatively small. Most of the respondents
(30.5%) had more than 15 years of experience in the medical field after getting a degree, while
19.5% of respondents had less than five years of experience. Similarly, most of the respondents
(45.9%) had more than 15 years of experience in the practice of their specialization. Nearly six
percent (6%) were practicing their specialization for less than five years. The physicians involved
in the study were situated in various regions where they are practicing their specialty. Most of
them, constituted by 27.6%, were from the Northern region, while the minority equivalent to
12.8% was from the Eastern region. For further details on the demographic and practice
characteristics of the study participants, refer to Table 2.
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Table 2: Demographic and practice characteristics of the study participants

Item

Frequency

Percentage

Male

234

47.5%

Female

259

52.5%

25 - 35

108

21.9%

36 - 45

143

29.0%

46 - 55

171

34.7%

over 55

71

11.6%

Saudi

218

44.2%

Non-Saudi

275

55.8%

Board-certified

257

52.1%

Not board-certified

236

47.9%

Less than 5

46

19.5%

5-10

52

22.0%

11-15

66

28.0%

More than 15

72

30.5%

Less than 5

16

6.2%

5-10

52

20.2%

11-15

71

27.6%

More than 15

118

45.9%

Gender

Age

Nationality

Board Certification

Years of experience in medical field after the degree

Years of experience in specialty

Region where specialty is practiced
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Northern region

136

27.6%

Central region

120

24.3%

Western region

68

13.8%

Eastern region

63

12.8%

Southern region

106

21.5%

4.2 Participants Characteristics and their perception about the utility of clinical guidelines
To examine the perception of physicians on the utility of using diabetes guidelines, a set
of statements were given to the respondents. Figure 2 shows the average response from the 493
respondents. It reflects that, on average, physicians agreed that diabetes guidelines provide an
opportunity to contribute to an efficient use of resources, increases patients’ satisfaction with care,
saves time in patient care, decreases the risk of diabetes complications, and delivers evidencebased care.
Knowing how physicians in Saudi Arabia perceive the use of diabetes guidelines provides
more room to study more about the diabetes guidelines and their overall impact on patients’ wellbeing. This can be done by further analyzing the clinical guidelines through the medical journals
they have access to. These include paper journals, journals on the internet, and conferences.
Moreover, this can also lead to identifying other sources that can effectively guide physicians and
other healthcare providers more suitable for an individual patient with Type 2 Diabetes.
Furthermore, the promising results can lead to broader information dissemination to
enhance knowledge and awareness of other physicians and healthcare workers in managing Type
2 Diabetes among their patients.
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Figure 2. Perception of the respondents on following diabetes guidelines utility

4.2.1 Gender
As shown in Table 3, the responses of both male and female physicians reflect their positive
feedback on the utility of clinical guidelines. Approximately 70% agreed that clinical guidelines
are useful for managing patients with Type 2 diabetes. There was no significant difference between
the perception of male and female physicians regarding the usefulness of using diabetes guidelines
as indicated by a p-value greater than 0.05.
4.2.2 Age
Like the observation on the level of perception between male and female physicians, most
physicians from different age groups acknowledged the usefulness of diabetes guidelines on
managing patients with Type 2 diabetes. The p-value indicates that there was no significant
difference between the perception of physicians depending on their age.
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4.2.3 Nationality
The participants’ response regarding the utility of clinical guidelines on managing people
with Type 2 diabetes showed they agreed that using diabetes guidelines, in general, was useful.
The results also showed no significant difference in the perception of the utility of clinical
guidelines among physicians from Saudi Arabia in comparison to physicians from other countries.
This means that perceiving the utility of diabetes guidelines is the same regardless the nationality
of attending healthcare workers.
4.2.4 Board certification
Both board-certified physicians and those who were not agreed that clinical guidelines
were useful to manage patients with Type 2 diabetes. The results showed there was no significant
difference between the perception of board-certified and non-board-certified physicians regarding
the utility of diabetes guidelines. Although their responses reflected that they agreed on the
usefulness of diabetes guidelines, it can be observed that a relatively smaller mean was derived
from the responses of non-board-certified physicians, and those who had board certification were
a slightly higher mean.
4.2.5 Years of experience in medical field after the degree
Overall, the physicians’ responses, based on their years of experience in the medical field,
reflect that they agreed to the usefulness of using diabetes guidelines. Based on the resulting pvalue, there was a significant difference among physicians’ responses based on their years of
experience regarding their perception of the usefulness of utilizing clinical guidelines for
managing patients with Type 2 diabetes. Less experienced physicians were more likely to perceive
guidelines as useful.
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4.2.6 Years of experience in the area of specialization
It can be observed in Table 3 that all physicians except those who had more than 15 years
in their area of specialization agreed on the utility derived from using clinical guidelines for
patients with Type 2 diabetes. Interestingly, those who had more than 15 years in their area of
specialty strongly agreed on the usefulness of diabetes guidelines in the management of patients
with Type 2 diabetes. It was also found that there was no significant difference among physicians’
responses grouped according to years of experience in their respective specializations. This
highlights that years of experience in specialty did not affect physicians’ perception of the utility
of diabetes guidelines.
4.2.7 Region where specialty is practiced
The perception regarding the usefulness of using clinical guidelines among physicians in
different regions was different. Physicians from all regions agreed to a different degree that
following the diabetes guidelines is essential for managing patients with Type 2 diabetes. Notably,
their responses manifested a significant difference, as indicated by the p-value of less than 0.05.
Thus, there is sufficient evidence to say that physicians’ response from one region to another is
significantly different. Physicians who practice their profession in the Central region had the
highest perception score reflecting a more positive perception on the utility of diabetes guidelines
compared to others. It is worth mentioning that board certification and years of experience in
specialty were borderline significant in terms of their influence on physicians’ perception on the
utility of diabetes guidelines.
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Table 3. Physicians’ characteristics and their perception of the utility of diabetes guidelines

Item

Frequency

Percentage

Perception score

Male

234

47.5

19.4 ± 3.3

Female

259

52.5

19.2 ± 2.9

Total

493

100

25 - 35

108

21.9

19.8 ± 3.6

36 - 45

143

29.0

18.7 ± 3.0

46 - 55

171

34.7

19.3 ± 3.0

over 55

71

11.6

19.5 ± 2.5

Total

493

100

Saudi

218

44.2

19.5 ± 3.1

Non-Saudi

275

55.8

19.1 ± 3.1

Total

493

100

Board-certified

257

52.1

19.6 ± 3.1

Not board-certified

236

47.9

19.0 ± 3.2

Total

493

100

P-value

Gender
0.450

Age

0.159

Nationality
0.413

Board Certification
0.069

Years of experience in medical field after the degree
Less than 5 years

46

19.5

20.9 ± 2.9

5-10 years

52

22.0

19.4 ± 3.0

11-15 years

66

28.0

18.1 ± 3.1

More than 15 years

72

30.5

18.9 ± 2.9

Total

493

100

Years of experience in specialty
47

0.001a

Less than 5 years

16

6.2

19.0 ± 4.3

5-10 years

52

20.2

18.6 ± 3.5

11-15 years

71

27.6

19.5 ± 3.3

More than 15 years

118

45.9

19.9 ± 2.3

Total

257

100

0.085

Region where specialty is practiced

a

Northern region

136

27.6

18.4 ± 3.1

Central region

120

24.3

20.4 ± 2.8

Western region

68

13.8

18.9 ± 2.8

Eastern region

63

12.8

17.6 ± 3.9

Southern region

106

21.5

19.4 ± 3.5

≤0.001a

-significant using One-Way ANOVA test at <0.01 level.

4.3 Medical Specialty
Among the 493 physician respondents, most (28.8%) specialized in internal medicine. The
remaining physicians were those with specializations in primary care, family medicine, and
endocrinology. Those who chose “other” did not specify their specialty. As can be observed in
Table 4, their responses do not relatively vary significantly from one another, implying that
physicians from different specializations, in general, have the same perception of the utility of
diabetes guidelines.
The p-value indicates there was no significant difference among the responses of
physicians in terms of perception of the utility of diabetes guidelines.
4.4 Access to medical journals
Most of the respondents (63.1%) reported that they have attended conferences to stay
updated with the clinical guidelines regarding managing patients with Type 2 diabetes. Physicians
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relying on the internet corresponded to 51.3% of the total study sample. The remaining were those
who consult paper journals (Table 4). As evidenced, there was no significant difference between
physicians’ responses who consulted paper journals versus using the internet. Those who relied on
paper journals and the internet had nearly identical views on the utility of diabetic guidelines. In
general, they both thought that following diabetes guidelines was beneficial. Those who were more
likely to use journals (print or online) thought clinical guidelines were more useful than those who
relied on conferences.
4.5 Services available in clinic
Several services are available in clinics in Saudi Arabia to help manage patients with Type
2 diabetes. A significant difference was found among physicians who conduct specific clinic
services for Type 2 diabetes management (Table 4). These services included multidisciplinary care
coordination, self-monitoring blood glucose instruction and evaluation, weight-loss counselling,
and physical activity instruction, smoking cessation counselling, annual eye examination, diabetes
self-management education, and psychological/social status assessments.
4.6 Provider of the medical services
Most respondents mentioned that nurses (62.9%) commonly provided such services,
followed by physicians (46.2%) (Table 4). There was no statistically significant difference in the
mean perception score between different healthcare providers.
Table 3: Medical information of physicians and their perception score on the utility of diabetes guidelines

Variables

Frequency

Percentag
e

Perception Score

P-value

93

18.9

19.6 ± 3.3

0.157

Specialty
Primary Care Physician
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Family Medicine

137

27.8

18.8 ± 3.0

Internal Medicine

142

28.8

18.7 ± 3.1

Endocrinology

90

18.3

19.5 ± 3.0

Others

54

11.0

20.7 ± 3.1

Access to medical journals to stay updated with the guidelines
Paper Journals

219

44.4

20.1 ± 2.7

Internet

253

51.3

19.9 ± 3.4

Conferences

311

63.1

19.2 ± 2.9

Multidisciplinary care
coordination

148

30.0

20.1 ± 2.7

Self-monitoring blood glucose
instruction and evaluation

144

29.2

19.7 ± 2.6

Intensive insulin therapy
instruction

130

26.4

19.4 ± 3.0

Weight-loss counselling and
physical activity instruction

98

19.9

18.5 ± 3.1

Medical nutrition therapy

90

18.3

19.1 ± 3.1

Smoking-cessation
counselling

62

12.6

18.0 ± 3.0

Self-care of the feet education

75

15.2

19.0 ± 2.8

Annual eye examination

78

15.8

18.2 ± 3.0

Diabetes self-management
education

46

9.3

17.6 ± 3.4

Psychological/social status
assessments

113

22.9

19.7 ± 2.6

Physicians

228

46.2

19.8 ± 2.9

Diabetes Educators

95

19.3

19.6 ± 3.2

Nurses

310

62.9

19.3 ± 2.7

0.318

Services available in clinic

0.417

Who provides the services
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0.453

b

Social workers

140

28.4

19.6 ± 3.4

Others

139

28.2

20.1 ± 3.4

-significant using Welch's t-test at <0.05 level.

4.7 Participation in DPP and DSME
Thirty-five percent of the respondents shared that their clinic provided both a Diabetes
Prevention Program (DPP) and Diabetes Self-Management Education Program (DSME). A total
of 26.0% of the respondents disclosed that their clinic was involved only in DSME, while another
26% mentioned that their clinic did not participate in either. The minority, or 12% of total
respondents, said their clinic was involved in DPP only (Table 5). As can be noticed in Table 5,
those who shared that their clinics were participating in DPP had a relatively higher mean of
diabetes guidelines’ perception score. However, this difference did not reach the significance level,
as indicated by the p-value. It is worth mentioning that the DPP and DSME are programs
promulgated by the U.S. CDC.
4.8 Usage of guidelines
A slight majority of respondents (58.6%) shared that they are following diabetes guidelines
(Table 3). Notably, there was a significant difference in physicians’ responses regarding their
perception of the utility of diabetes guidelines. Those who followed the guidelines had a higher
diabetes guidelines’ perception score.
4.9 Guidelines used to manage diabetes
The largest number of respondents (46%) indicated that they utilize the European
Association for the Study of Diabetes (EASD) guidelines in managing diabetes, while 30.4% use
the International Diabetes Federation (IDF) Guidelines, and 20.8% follow the American Diabetes
Association (ADA) Guidelines (Table 5). A significant difference was seen in physicians’
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responses regarding their perception of the utility of diabetes guidelines. Remarkably, those who
followed ADA Guidelines had higher perceptions of guidelines’ utility. As indicated by the
diabetes guideline score, other respondents showed that they agreed to the utility of following
clinical guidelines.
Table 4: Utilization of guidelines in managing diabetes

Item

Count

Percent

Perception score

P-value

Clinic participation in Diabetes Prevention Program (DPP) or/and Diabetes SelfManagement Education program (DSME)e
DPP only

59

12.0

19.5 ± 2.9

DSME only

128

26.0

18.7 ± 3.3

DPP and DSME

174

35.4

19.5 ± 2.8

None

131

26.6

19.5 ± 3.4

0.118

Usage of guidelines to manage diabetes
Used guidelines

289

58.6

19.7 ± 2.9

Did not use guidelines

204

41.4

18.6 ± 3.4

<0.001a

Guidelines used to manage diabetes d
American Diabetes
Association (ADA) Guidelines

60

20.8

21.1 ± 2.6

International Diabetes
Federation (IDF) Guidelines

88

30.4

18.9 ± 3.1
≤0.001

European Association for the
Study of Diabetes (EASD)
Guidelines
Other
a

133

46.0

19.6 ± 2.6

8

2.8

20.3 ± 2.5

-significant using Welch's t-test at <0.05 level.
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4.10 Physicians Guidelines Utility Perception and Adherence to Clinical Guidelines
The following tables show the results of fitting a multivariate model with covariates
significant at the 0.25 level in the univariable analysis. Hosmer et al., (2013) asserted that the use
of a p-value less than 0.25 portrays clinical importance. Moreover, they used the work of Bendel
and Afifi in 1977 on linear regression and by Mickey and Greenland in 1989 about logistic
regression for applying 0.20 or 0.25 level of significance as a criterion in appropriate initial
variable selection. Hosmer et al., (2013) also mentioned that the use of a more traditional level-the
use of a 0.05 level of significance “often fails to identify variables known to be important”.
Given these circumstances for using p-value of 0.25, Table 6 presents multiple linear
regression analysis for those physicians who reported “following guidelines” in managing diabetes
where the dependent variable was the physician’s perception score and the independent variables
were physicians’’ characteristics that significantly affected physicians’ perception scores (Board
Certification, years of experience in specialty, region where physicians practice, and the
availability of DPP and DSME programs). Results indicate that having five to ten years of
experience in practicing specialty significantly attributed to physicians’ perception of Type 2
diabetes guidelines utility. As indicated by the negative coefficient, this denotes that within the
five to ten years of experience, a one-year less increment of experience could result in a relatively
higher score on the usefulness of such guidelines. Hence, this implies that those who had relatively
lower years of experience within five to ten years were more likely to adhere to guidelines.
The participation of clinics in the Diabetes Prevention Program (DPP) and the Diabetes
Self-Management Education Program (DSME) did not significantly affect the perception towards
diabetes guidelines utility. Both portrayed a negative coefficient, meaning physicians would
perceive guidelines with a higher utility when a clinic does not participate in either of the two.
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When all these variables (board certification, years of experience in specialty, region of
practice, and participation in DPP and/or DSME) are equal to zero, the diabetes guideline
perception score, as indicated by the value of the intercept, will be 93.899. This implies that
physicians strongly agree to the usefulness of the diabetes guidelines and reflected in their
adherence to the clinical guidelines.
Table 5: Linear regression analysis showing the relationship between physicians’ characteristics and
perceptions guideline utility and guideline adherence

Parameter Estimates a
Dependent Variable: Perception of diabetes guidelines
utility

B

p-value

93.899

<0.001

R square: 0.152
Intercept

0b

Board-certified = Yes

a

Years of experience in your specialty =Less than 5 years

-4.161

0.355

Years of experience in your specialty =5 – 10 years

-7.396

0.005

Years of experience in your specialty=11 – 15 years

-0.311

0.892

Region where the physician practices = Northern region

-5.090

0.063

Region where the physician practices = Central region

2.162

0.435

Region where the physician practices = Western region

0.729

0.831

Region where the physician practices = Eastern region

-4.773

0.139

Participation of clinic in Diabetes Prevention Program (DPP)
or/and Diabetes Self-Management Education Program
(DSME)=DPP only

-16.923

0.102

Participation of clinic in Diabetes Prevention Program (DPP)
or/and Diabetes Self-Management Education program
(DSME)=DSME only

-18.174

0.075

Participation of clinic in Diabetes Prevention Program (DPP)
or/and Diabetes Self-Management Education program
(DSME)=DPP and DSME

-11.308

0.267

-Do you use guidelines to manage diabetes? = Yes
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-This parameter is set to zero because it is redundant.

Tables 7 presents multiple linear regression analysis for those physicians who reported “not
following guidelines” in managing diabetes where the dependent variable was the physician’s
perception score and the independent variables were physicians’’ characteristics that significantly
affected physicians’ perception scores (Board Certification, years of experience in specialty,
region where physicians practice, and the availability of DPP and DSME programs) The years of
experience in the specialty and region where they practiced described the view of the utility of
guidelines linked to the high chance of non-adherence to guidelines. Those who had experience of
fewer than five years in their specialty were significantly related to having a better perception of
the diabetes guidelines utility, as denoted by the positive coefficient. However, it was also reported
that they were also more likely to not adhere to diabetes guidelines.
When all these variables (board certification, years of experience in specialty, region of
practice, and participation in DPP and/or DSME) are equal to zero, the diabetes guideline score,
as indicated by the value of the intercept, will be 68.077, implying that the respondents somewhat
agreed that the guidelines were useful.
Table 7: Linear regression analysis showing the relationship between physicians’ characteristics and
perception on guidelines utility and being non-adherent

Parameter Estimates a
Dependent Variable: Perception of diabetes guidelines
utility

B

p-value

68.077

<0.001

R Square: 0.166
Intercept
Board-certified = Yes

0b

Years of experience in your specialty =Less than 5 years
55

19.493

0.011

a

Years of experience in your specialty =5 – 10 years

7.569

0.492

Years of experience in your specialty=11 – 15 years

-3.013

0.746

Region where the physician practices = Northern region

-16.779

0.088

Region where the physician practices = Central region

-5.228

0.606

Region where the physician practices = Western region

-7.327

0.514

Region where the physician practices = Eastern region

0.274

0.990

Participation of clinic in Diabetes Prevention Program (DPP)
or/and Diabetes Self-Management Education program
(DSME)=DPP only

-7.146

0.568

Participation of clinic in Diabetes Prevention Program (DPP)
or/and Diabetes Self-Management Education program
(DSME)=DSME only

-5.920

0.580

Participation of clinic in Diabetes Prevention Program (DPP)
or/and Diabetes Self-Management Education program
(DSME)=DPP and DSME

4.103

0.660

-Do you use guidelines to manage diabetes? = No

b

-This parameter is set to zero because it is redundant.

Table 8 presents a multiple linear regression analysis for those physicians who reported
“following guidelines” in managing diabetes where the dependent variable was the physician’s
perception score and the independent variables were medical-related information that significantly
affected physicians’ perception scores (access to medical journals, services provided in clinic, and
who provide these services). The use of paper journals to stay updated with the clinical guidelines
was found to be positively and significantly related to the perception of the utility of clinical
guidelines. This leads to a high likelihood of following guidelines in managing patients with Type
2 diabetes.
The availability of services provided in the clinics was observed to be significantly related
to the perception of the utility of diabetes guidelines. As the negative coefficients imply, the
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unavailability of such services (weight-loss, smoking-cessation, diabetes self-management
education, and psychological/social status assessments) creates a positive leaning on the
perception of the usefulness of clinical guidelines. This leads them to be more likely to adhere to
clinical guidelines. This can imply a need to improve such services in order to manage patients
with diabetes more efficiently.
It is also notable that when physicians provide these services, the respondents shared a
better perception of the usefulness of diabetes guidelines. This, in turn, is reflected in a high
likelihood of adherence to diabetes guidelines.
When all these variables are equal to zero, the diabetes guidelines’ perception score, as
indicated by the value of the intercept, will be 71.185. This denotes that the respondents lean more
on the perception that the diabetes guidelines are useful and, thus, it is worthy of being followed
or utilized.
Table 8: Linear regression analysis showing the effect of medical-related information of respondents and
perception of diabetes guidelines that affect adherence to guidelines

Parameter Estimates a
B

P-value

Intercept

71.185

<0.001

Access to medical journals to stay updated with the guidelines=Paper
Journals

5.387

0.002

Access to medical journals to stay updated with the
guidelines?=Internet

3.082

0.063

Services provided in clinic=Multidisciplinary care coordination

0.662

0.739

Services provided in clinic =Self-monitoring blood glucose
instruction and evaluation

-3.180

0.075

Dependent Variable: Perception of diabetes guidelines utility
R Square: 0.099
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a

Services provided in clinic = Weight-loss counselling and physical
activity instruction

-7.969

<0.001

Services provided in clinic = Smoking-cessation counselling

-5.684

0.041

Which services do you provide in your clinic?=Annual eye
examination

-3.564

0.160

Services provided in clinic=Diabetes self-management education

-5.878

0.043

Services provided in clinic = Psychological/social status assessments

-4.768

0.016

Personnel who provides these services=Physicians

6.742

0.001

Personnel who provides these services =Diabetes Educators

2.772

0.151

-Do you use guidelines to manage diabetes? = Yes

Table 9 presents multiple linear regression analysis for those physicians who reported “not
following guidelines” in managing diabetes where the dependent variable was the physician’s
perception score and the independent variables were medical-related information that significantly
affected physicians’ perception scores (access to medical journals, services provided in clinic, and
who provide these services). As can be seen, the use of the internet for accessing medical journals
is statistically and positively related to the perception of diabetes guidelines utility. However, this
perception from this source of information leads to a higher likelihood of not adhering to
guidelines. This can denote that perhaps physicians need to evaluate sources accessed on the
internet which can affect their perception of the utility of guidelines.
Moreover, clinics that provide Diabetes Self-Management Education (DSME) tended to
have a lower score on the perception of diabetes guidelines utility. This creates a higher likelihood
of not adhering to the clinical guidelines. This can imply room for improvement and reassessment
of such a program in a way that can help both the physicians and the patients.
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When physicians were the ones who provided these recommended services, this created a
positive impact on the perception of diabetes guidelines score. However, the likelihood of not
adhering to guidelines was high.
Table 9: Linear regression analysis showing the effect of medical-related information of respondents and
perception of diabetes guidelines that affect non-adherence to guidelines

Parameter Estimates a
B

P-value

Intercept

64.384

<0.001

Access to medical journals to stay updated with the guidelines=Paper
Journals

-0.434

0.888

Access to medical journals to stay updated with the
guidelines?=Internet

7.768

0.005

Services provided in clinic=Multidisciplinary care coordination

1.077

0.791

Services provided in clinic =Self-monitoring blood glucose
instruction and evaluation

6.658

0.108

Services provided in clinic = Weight-loss counselling and physical
activity instruction

1.513

0.670

Services provided in clinic = Smoking-cessation counselling

-2.103

0.571

Which services do you provide in your clinic?=Annual eye
examination

-2.920

0.398

Services provided in clinic=Diabetes self-management education

-10.480

0.020

Services provided in clinic = Psychological/social status assessments

5.976

0.218

Personnel who provides these services=Physicians

6.742

0.001

Personnel who provides these services =Diabetes Educators

2.772

0.151

Dependent Variable: Perception of diabetes guidelines utility
R Square: 0.055

a

-Do you use guidelines to manage diabetes? = No

When we conducted multiple linear regression analysis for those physicians who reported
“following guidelines” in managing diabetes where the dependent variable was the physician’s
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perception score and the independent variables were all variable related to physicians’ practices
characteristics (age, gender, region of practice, years of experience after getting the degree, years
of experience in specialty, Clinic participation in Diabetes Prevention Program (DPP) or/and
Diabetes Self-Management Education program (DSME), board certification, access to medical
journals, and service availability) to explore the relationship between physicians’ characteristics
and perceptions guideline utility and guideline adherence the R-square become 0.231 and being
board certified, participation of clinic in Diabetes Prevention Program (DPP) or/and Diabetes SelfManagement Education program (DSME)=DSME only, practicing in the Northern and Eastern
regions, being aged (36 – 55 years), and having practice experience more than five years were
significant variables that affected guidelines adherence.
When we conducted multiple linear regression analysis for those physicians who reported
“not following guidelines” in managing diabetes where the dependent variable was the physician’s
perception score and the independent variables all variable related to physicians’ practices
characteristics (age, gender, region of practice, years of experience after getting the degree, years
of experience in specialty, Clinic participation in Diabetes Prevention Program (DPP) or/and
Diabetes Self-Management Education program (DSME), board certification, and service
availability) to explore the relationship between physicians’ characteristics and perceptions
guideline utility and guideline non-adherence the R-square become 0.210, and having experience
5-10 years was significant variable that affected guidelines non-adherence.

4.11 Physicians guidelines utility perception as a mediator for clinical guidelines adherence
Binary logistic regression analysis where the dependent variable was (following
guidelines? Yes/No) and the independent variables were (gender, age, nationality, board
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certification, years of experience after medical degree, years of experience in specialty, Region
where physicians practice, and the availability of DPP and DSME) identified that physicians who
are over 55 years of age and those who reported having over 5 years of experience in specialty
were more likely to use clinical guidelines to manage Type 2 diabetes patients (p≤0.01). On the
other hand, non-Saudi physicians and those who were not board-certified were less likely to use
clinical guidelines to manage Type 2 diabetes patients compared to others (p≤0.01). Also, it
showed that those physicians who participate in DSME were more likely to follow guidelines
(p≤0.001), and the same for those who participate in DPP and DSME (p≤0.001) (Table 10).
In order to explore the role of physicians’ perception (as a mediating variable) on the
utilization of clinical guidelines to manage Type 2 diabetes patients, a mediation analysis (Model
4) was conducted. Physicians’ perception was placed as a mediator and physicians’ demographic
and practice characteristics were placed as independent variables, and the utilization of clinical
guidelines to manage Type 2 diabetes patients was placed as the dependent variable.
Mediation analysis indicated that physicians’ perception of guideline utility showed a
negative mediation effect for the age group 36-45 years and those who reported duration of
experience of 11-15 years after obtaining their degree on their utilization of clinical guidelines to
manage Type 2 diabetes patients. At the same time, physicians’ perception showed a positive
mediation effect for those who reported a duration of experience in the specialty of 15 years and
above. Also, physicians’ perception showed a positive mediation effect for those who practice in
the Northern Region, while physicians’ perception showed a negative mediation effect for those
who practice in the Eastern Region. Moreover, physicians’ perception showed a negative
mediation effect for those who participate in DSME only (Table 10).
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Table 10: Binary logistic regression analysis and mediation analysis

Item

Odds ratio of
using clinical
guidelines to
manage patients

Pvalue

Mediation
effect of
perception
on odds ratio
of using
clinical
guidelines

Boot LLCI –
Boot ULCI

Gender
Male (Reference group)
Female

1.00
1.32 (0.92-1.90)

0.126

No mediation
effect

-0.0240 to 0.7857

Age (years)
25 – 35 years (Reference
group)

1.00

36 – 45 years

0.87 (0.59-1.28)

0.477

There is a
mediation
effect

-0.0875 (-0.1960
to -0.0100)

46 – 55 years

1.23 (0.84-1.80)

0.281

No mediation
effect

- 0.0752 to 0.0754

over 55 years

2.31 (1.31-4.1)

0.004*
*

No mediation
effect

- 0.0495 to 0.1488

≤0.001
***

No mediation
effect

-0.0186 to 0.0027

≤0.001
***

No mediation
effect

-0.1747 to 0.0079

Nationality
Saudi (Reference group)
Non-Saudi

1.00
0.85 (0.81-0.90)

Board Certification
Board-certified (Reference
group)
Not board-certified

1.00
0.05 (0.03-0.08)

Years of experience in medical field after the degree (years)
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1.00

Less than 5 years (Reference
group)
5-10 years

0.14 (0.07-0.28)

≤0.001
***

No mediation
effect

- 0.1194 to 0.1563

11-15 years

0.20 (0.11-0.35)

≤0.001
***

There is a
mediation
effect

- 0.1297 (-0.2873
to -0.0221)

More than 15 years

0.47 (0.29-0.79)

0.004*
*

No mediation
effect

- 0.2154 to 0.0060

Years of experience in specialty (years)
Less than 5 (Reference group)

1.00

5-10 years

5.17 (2.28-11.71)

≤0.001
***

No mediation
effect

- 0.2587 to 0.0388

11-15 years

5.17 (2.58-10.36)

≤0.001
***

No mediation
effect

- 0.0851 to 0.1411

11.51 (5.8422.69)

≤0.001
***

There is a
mediation
effect

0.0921 (0.0128 to
0.1998)

0.882

There is a
mediation
effect

0.3026 (0.1121 to
0.5603)

0.486

No mediation
effect

0.0068 (-0.1438 to
0.1606)

0.55 (0.21-1.42)

0.217

No mediation
effect

0.1337 (-0.0250 to
0.3528)

0.59 (0.32-1.08)

0.084

There is a
mediation
effect

-0.1951 (-0.4046
to -0.0440)

More than 15 years

Region where specialty is practiced
Region where the physician
practices = Northern region
(Reference group)
Region where the physician
practices = Northern region
Region where the physician
practices = Central region
Region where the physician
practices = Western region
Region where the physician
practices = Eastern region

1.00
0.94 (0.39-2.26)

0.75 (0.34-1.68)

Clinic participation in Diabetes Prevention Program (DPP) or/and Diabetes SelfManagement Education program (DSME)
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Participation of clinic in
Diabetes Prevention Program
(DPP) or/and Diabetes SelfManagement Education
program (DSME)=DPP only
(Reference group)

1.00

Participation of clinic in
Diabetes Prevention Program
(DPP) or/and Diabetes SelfManagement Education
program (DSME)=DSME only

3.71 (2.31-5.98)

≤0.001
***

There is a
mediation
effect

-0.1247 (-0.2581
to -0.0212)

Participation of clinic in
Diabetes Prevention Program
(DPP) or/and Diabetes SelfManagement Education
program (DSME)=DPP and
DSME

3.37 (2.23-5.09)

≤0.001
***

No mediation
effect

0.0404 (-0.0240 to
0.1297)
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Chapter 5: Discussion
5.1 Discussion
The aim of this research was to assess physicians’ perception of the utility of clinical
guidelines in the management of people with Type 2 diabetes in Saudi Arabia. The key findings
of this research are: 1) physicians’ perception about the utility of clinical guidelines significantly
differed based on years of experience after obtaining their degree, the region of practice, utilization
of clinical guidelines to manage their patients, and the types of clinical guidelines used to manage
Type 2 diabetes patients; 2) having five to ten years of experience in practicing specialty negatively
affect physicians’ perception towards the utility of clinical guidelines; 3) physicians who are aged
over 55 years and those who reported having years of experience in specialty over 5 years were
more likely to use clinical guidelines to manage Type 2 diabetes patients (p≤0.01); and 4)
physicians’ perception showed a negative mediation effect for the age group 36-45 years and those
who reported duration of experience of 11-15 years after obtaining their degree on their utilization
of clinical guidelines to manage Type 2 diabetes patients. At the same time, physicians’ perception
showed a positive mediation effect for those who reported duration of experience in the specialty
of 15 years and above.
In our study, both male and female physicians expressed positive feedback on the utility of
clinical guidelines, with no gender-based variations in how useful they thought they were.
Approximately 70% showed they agree that clinical guidelines are useful for managing patients
with Type 2 diabetes. There was no significant difference between the perception of male and
female physicians regarding the usefulness of using diabetes guidelines. This was aligned with the
findings of a previous study by Somily et al., which reported no significant difference between
adherence of males and females to diabetes guidelines (Somily, 2017). On the other hand, a cross65

sectional study done by Berthold et al., suggests that female physicians provide better quality care
for diabetic patients than their male counterparts primarily because female physicians tend to use
a more participative style of decision-making which is a fundamental component in the diabetes
care (Berthold, 2008). Similarly, there was no significant difference in physicians’ perception
based on their age. Two studies are incongruent with the result of this study. Somily et al., observed
less adherence to Diabetes Guidelines among physicians less than thirty years old (Somily, 2017).
Meanwhile, Mehta et al., found that more senior physicians in the USA (age group 35-44 years
and 45-55 years) were less likely to report using the United States Preventive Services Taskforce
guidelines compared to younger physicians (25-44 years age group) (Mehta, Mocarski et al.,
2017). Despite that, there is a need for improving the utilization of clinical guidelines on managing
diabetes patients regardless of the physician’s age. On the other hand, there was a significant
difference in physicians’ perceptions based on their years of experience. This can indicate that they
have varying levels of perspective regarding medical care towards diabetes patients using the
prescribed clinical guidelines. In addition, it paves the way for harnessing the knowledge and skill
of healthcare workers regarding the utilization of diabetes guidelines specifically for senior
physicians. Confirming the findings of our study, Somily et al., reported a low level of adherence
to diabetes guidelines among physicians with less experience in the primary health care practice
(Somily, 2017). On the other hand, this result was different from a study conducted by Brenner et
al. (2020). According to their research, physicians in the USA who have more than ten years of
experience with Type 2 diabetes patients were much less likely to adhere to diabetes guidelines
(Brenner, 2020).
In our study, there was no statistically significant difference in physicians’ perception
based on their years of experience in their respective specialization. This can imply that a vast
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medical experience in practicing respective specializations is not necessarily associated with a
better comprehensive understanding of the utility of the guidelines that one can get from utilizing
diabetes guidelines.
Physicians’ nationality also did not affect their perception of the utility of clinical
guidelines. This was different from the findings of a previous study in Saudi Arabia which
concluded that Saudi physicians were less adherent to diabetes guidelines, which justified that nonSaudi physicians may be subjected to stricter employment qualifications (Somily, 2017).
Medical specialty did not affect physicians’ perception about the utility of clinical
guidelines and all participating physicians reported similar responses that did not differ
significantly. This can provide a positive insight that physicians, despite differences in
specializations, can perceive using diabetes guidelines as good, leading to harnessing their medical
strength.
Being a board-certified physician did not significantly affect physicians’ perception about
the utility of clinical guidelines. A slightly higher perception score could reflect that boardcertified physicians are more convinced that using diabetes guidelines is useful for patients. These
insights indicate a call for physicians in Saudi Arabia to put more focus on achieving board
certification. This way more physicians can expand their knowledge in terms of utilizing diabetes
guidelines in the management of patients with Type 2 diabetes. Another important factor that
affected physicians’ perception about the utility of clinical guidelines was the region of practice.
In our study, we found that physicians’ response from one region to another is significantly
different. This could be attributed to the fact of having different managerial procedures followed
by senior physicians and healthcare managers which could be affected by their clinical and practice
backgrounds (Alkhiari, Alzayer et al., 2018). At the same time, there are multiple confounding
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factors that could have influenced these findings such as the distribution of physicians at different
regions in Saudi Arabia based on their experience and qualifications which could possibly be
inconsistent. Amer et al., in their study reported that the context or health care setting at the
institution where evidence-based medicine and CPGs are part of the undergraduate and
postgraduate medical school curricula, was one of the most important contributing factors that
positively affect physician perception (Amer, Nemri et al., 2019). They also reported that
engagement in continual quality improvement projects and efforts as a result of national and
international accreditation activities is another important factor that improved physician perception
and adherence to clinical guidelines (Amer, Nemri et al., 2019). Additionally, previous literature
stressed the necessity for enhancing continuous medical education among medical practitioners
and potential training in the treatment and management of diabetes (Corriere, Minang et al., 2014).
Several services are available at clinics in Saudi Arabia to help manage patients with Type
2 diabetes. A significant difference was found among physicians who conduct specific clinic
services for Type 2 diabetes management. This means that responses can significantly vary
depending on the availability of such services in their respective clinics.
Clinic participation in Diabetes Prevention Program (DPP) and Diabetes Self-Management
Education Program (DSME) did not significantly affect the perception of physicians in our study.
Despite this, participating in both DPD and DSME can lead to a higher level of understanding and
better perception of the utility of diabetes guidelines to manage people with Type 2 diabetes. This
can imply a need to validate or reassess the efficiency of DPP and DSME and whether clinics
needed to employ another program/s that can help manage patients with diabetes type 2. On the
other hand, those who followed the guidelines had a higher diabetes guidelines’ perception score,
which implies that those who followed guidelines strongly agreed that following clinical
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guidelines was of utter importance in managing patients with Type 2 diabetes. In addition to this,
even the type of guidelines used was another important factor that affected physicians’ perception
score and those who used ADA showed higher perception scores relative to others. Wahabi et al.,
reported that certain circumstances improve health care providers' use and adherence to CPGs,
such as when the guideline's source is a credible and respected body or organization, when there
is consensus about the benefit to patients, and when supplies for implementation, such as medicine
and equipment, are available (Wahabi, Alzeidan et al., 2011). Physicians' judgments of
DPP/DSME utility, as well as utility perceptions following clinic resources, may well play a role
in clinic adoption of those approaches.
According to our study findings, having five to ten years of experience in practicing
specialty was negatively affecting physicians’ perception towards the utility of clinical guidelines.
This was confirming the findings of a previous study that was conducted in Canada. The authors
reported that compliance level to clinical guidelines was better with more clinical seniority and
training (Alkhiari, Alzayer et al., 2018). This calls for a need to strengthen more research on the
utility of guidelines in managing patients with Type 2 diabetes to build more confidence among
physicians in managing their patients. Another important study finding was that those who had
experience of fewer than five years in their specialty were more likely to not adhere to diabetes
guidelines. This can imply that physicians with less than five years of specialty need to be more
aware and equipped for applying clinical guidelines in managing patients with Type 2 diabetes.
Clinics must pursue more activities or programs for physicians with less than five years of medical
experience in order to gain a broader perspective that may result in better perception, thus leading
to adherence to the guidelines.
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Physician perception concerning the utility of clinical guidelines has influenced the
relationship between physicians’ demographic and practice characteristics and their adherence to
clinical guidelines. Some of our most important philosophers have long recognized that perception
(or the activation of a perceptual representation) can lead to equivalent overt behavior. The
assumption behind this concept is that, in addition to perceptual or cognitive representations (e.g.,
attributes, stereotypes), behaviors are also cognitively represented, and that these perceptual and
behavioral representations are somehow intertwined. Percepts and acts are perfectly matched and
continuous. Both percepts and acts relate to events having similar characteristics. The main
difference is that percepts correspond to ongoing, actor-independent events, whereas acts refer to
to-be-generated, actor-dependent events (Dijksterhuis, 1998). It is also worth mentioning that there
are many unknown factors that could affect physicians’ adherence to guidelines. This might
include promotional efforts directed towards healthcare professionals by pharmaceutical
companies. The cost might also be another factor that affects physicians’ adherence to clinical
guidelines as some patients might demonstrate cost-related non-adherence (Naser 2021; Ali, Naser
et al., 2022).
5.2 Policy Implications
Although the results showed there is no difference between Saudi and non-Saudi
physicians regarding the perception of the utility of diabetes guidelines, there is an opportunity for
improvement that include:
•

Restructuring Board-Certification Programs by incorporating clinical and non-clinical
sessions that discuss the importance and benefits of using guidelines when treating patients
with type 2 diabetes to improve both patients' outcomes and the quality of provided
healthcare services. (EBM)
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•

Facilitating the dissemination of knowledge and Evidence-Based Medicine (EBM) by
providing easy and reliable access to medical journals and improving the quality and
quantity of symposiums and workshops focusing on treating type 2 diabetes.

•

Encouraging physicians to attend these sessions, symposiums, and workshops by
rewarding them with academic hours as each physician must attend a required number of
academic hours to renew their medical license.
For non-Saudi physicians, the Ministry of Health in Saudi Arabia should improve the

standards that qualify non-Saudi physicians to practice in Saudi Arabia. Furthermore, the
healthcare system in Saudi Arabia faces a massive shortage in the number of Saudi physicians,
making the need for highly skilled and knowledgeable physicians a must as they represent more
than 50% of the workforce in the medical field. In addition, these physicians would help
disseminate the knowledge and skills required not only in treating diabetes but also in all other
medical specialties.
Regarding the availability of services, the results showed that several services were
available across all regions of Saudi Arabia. On the other hand, the results also showed a
considerable opportunity for improvement in service availability. One of the solutions would be
increasing the number of diabetes centers that offer all the required healthcare services for patients
with Type 2 diabetes. There are a few diabetes centers in Saudi Arabia right now, but they are
located in only 3-4 major cities. There should be at least one diabetes center in each major city of
all regions of Saudi Arabia because these services are critical to implementing diabetes guidelines,
improving diabetes outcomes and patient satisfaction.
Regarding the availability of the Diabetes Prevention Program (DPP) and Diabetes SelfManagement Education Program (DSME), the recommendation for service availability also
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applies here. DPP and DSME are important as they help mitigate the burden of diabetes spending
by decreasing the incidence of diabetes by identifying the population at high risk and intervening
to stop their progress to diabetes, which results in decreased spending on related services and
complications.
This research has multiple strong points. First, the study population included physicians
from all specialty with no restrictions. Physicians from all regions in the Kingdom were included.
The relatively large sample size increases the generalizability of the study findings. It is also worth
mentioning that in this research the logistic regression analysis applied the 0.20 or 0.25 level of
significance as a criterion in appropriate initial variable selection, which was recommended by
previous literature as standards for “clinical” and scientific criteria. This increases the reliability
of the variable identified from the regression analysis in this research.
At the same time, there were also limitations to this research. Due to the small sample size
for each sub-group, this research was unable to distinguish from the data the percentages for each
type of service by profession (physicians, nurses, etc.). Therefore, the findings of this research
should be interpreted carefully. The cross-sectional nature of the study design might also have
affected the ability of this research to explore causality. Desirability bias is expected from
participants, and rather than responding truly, they choose to answer questions about how their
comments will be understood by others. Respondents will select either socially acceptable or
politically correct replies.
5.3 Opportunities for Future Research
There are findings in this study that highlight opportunities for future research that must
be addressed. In this study, we assessed physicians’ perception of the utility of diabetes
guidelines, and, in general, it was positive. To see the whole picture, we must study the effect of
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this positive perception on the outcomes for patients regarding the management of diabetes.
Also, it would help to find other gaps in achieving the best care for patients with Type 2 diabetes.
In addition, we should study the effect of this positive perception on the prevalence of diabetes
because all diabetes guidelines from different international diabetes associations include
recommendations for prevention and early detection of pre-diabetes that allow for intervention
before progressing to diabetes.
Also, the results showed physicians who followed American Diabetes Association
(ADA) guidelines had a higher perception score than physicians who followed other guidelines.
On the other hand, the European Association for the Study of Diabetes (EASD) guidelines were
the most followed guidelines in Saudi Arabia. For a country with a high prevalence rate of
diabetes, such as Saudi Arabia, there should be a Saudi guideline for managing diabetes as
treating diabetes was a challenge since the early stages of developing the health care system.
Another option would be the adoption of one of the already published guidelines to be followed
throughout Saudi Arabia. This will lead to an important research question “Which guideline has
the best outcome for the patients?”. From the results of this study, three main guidelines were
followed: European Association for the Study of Diabetes (EASD) guidelines were followed by
46% of physicians, 30.4% followed the International Diabetes Federation (IDF) Guidelines, and
20.8% followed the American Diabetes Association (ADA) Guidelines. This diversity would be
an advantage in answering this question since we can study the outcome of each guideline.
Also, the results showed the availability of services recommended by guidelines is low.
Furthermore, we should study whether these services are provided by the government for free or
by the private section since these services are necessary for the ideal management of diabetes
and would be an additional burden on patients in the absence of medical insurance which would
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raise an issue of accessibility. Another important finding related to the availability of services is
that only 9% of physicians provided diabetes self-management education to their patients. This is
critical for patients as they must be able to make decisions to either increase or decrease the dose
for certain situations such as low or high blood glucose levels.
Also, the results showed physicians who practice at clinics participating in Diabetes
Prevention Program (DPP) and/or Diabetes Self-Management Education Program (DSME) had a
lower perception score. One explanation for these results could be the way these programs were
applied was demanding in effort and time. We should investigate these programs and how they
were applied resulting in unexpected perceptions since these programs are recommended by
diabetes guidelines.
5.4 Conclusion
In general, physicians' perception of the utility of diabetes guidelines is positive. This is a
good sign to achieve optimum care for patients with Type 2 diabetes. Nevertheless, there are
other parts of the healthcare system that should be investigated and improved. These parts
include the government, which owns and governs most hospitals in Saudi Arabia, healthcare
centers (hospitals and primary healthcare centers), and patients. The government should upgrade
the healthcare system's infrastructure to acquire new changes required for achieving optimum
care. Healthcare centers should prepare the environment and facilitate the implementation of
guidelines. Patients should also be compliant with physicians' recommendations as without
patients' compliance nothing could be achieved. If all these parts work together for improvement,
optimum care will be achievable.
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